{
  "pmid": "PMID:41545416",
  "title": "Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.",
  "abstract": "Optic glioma, a slow-growing tumor, is associated with Neurofibromatosis type 1 (NF1) mutations and increased midkine (MDK) production. A connection between asthma and optic glioma has previously been observed, but the mechanisms are unclear. To elucidate the role of asthma in the regulation of glioma formation, we investigated the role of T cells and the subsequent pathways in the regulation of microglia, a key player in the glioma tumor microenvironment (TME). While asthma is often linked to chronic inflammation, our mathematical analysis and experimental evidence suggest that inflammation can play a key role in suppressing the proliferation of optic glioma cells via immune reprogramming of T cells and the delicate control of signaling networks in microglia. Our mathematical model unveils the complex interactions between tumor and immune cells in optic glioma. Our results indicate that asthma-induced T cell reprogramming inhibits tumor growth by promoting the release of decorin and a subsequent suppression of CCR8 and the intercellular binding kinetics in microglia, followed by blocking of CCL5 production in TME via suppression of NF\u03baB. We developed anti-cancer strategies by leveraging this asthma-induced immune regulation.",
  "authors": "Donggu Lee; Sean Lawler; Yangjin Kim",
  "journal": "NPJ systems biology and applications",
  "publicationDate": "2026-01-16",
  "doi": "10.1038/s41540-026-00647-w",
  "methods": "Methods In this section, we develop a mathematical model based on asthma-controlled immune\u2013glioma interactions (Fig.  1 ; optic nerve, T cells, microglia, and optic glioma cells). Receptor binding kinetics CCL4 ([ L 4 ]) binds to its receptors, CCR5 ([ R 1 ])  and CCR8 ([ 14 \u2013 17 R 2 ]) , on microglia, forming complexes ( 18 \u2013 20 ) that induce up-regulation of NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}],[\\overline{{L}_{4}\\cdot {R}_{2}}],$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] , [ L 4 \u22c5 R 2 \u00af ] , \u03ba B . These receptor binding kinetics are 21 \u2013 23 14 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{1}]\\mathop{\\mathop{\\rightleftharpoons }\\limits^{{b}_{1}^{+}}}\\limits_{{b}_{1}^{-}}[\\overline{{L}_{4}\\cdot {R}_{1}}],$$\\end{document} [ L 4 ] + [ R 1 ] \u21cc b 1 + b 1 - [ L 4 \u22c5 R 1 \u00af ] , where  15 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{2}]\\mathop{\\mathop{\\rightleftharpoons }\\limits^{{b}_{2}^{+}}}\\limits_{{b}_{2}^{-}}[\\overline{{L}_{4}\\cdot {R}_{2}}],$$\\end{document} [ L 4 ] + [ R 2 ] \u21cc b 2 + b 2 - [ L 4 \u22c5 R 2 \u00af ] ,  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 +  are the association rates of CCL4 to the CCR5 and CCR8 receptors, respectively,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 +  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 -  are the dissociation rate of the CCL4\u2013CCR5 and CCL4\u2013CCR8 complex, respectively. Here, we also have a conservation condition that the total number  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 -  of CCR5 receptor molecules remains constant, i.e., \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${[{R}_{1}]}_{{\\rm{T}}}$$\\end{document} [ R 1 ] T 16 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{R}_{1}]+[\\overline{{L}_{4}\\cdot {R}_{1}}]={[{R}_{1}]}_{{\\rm{T}}}.$$\\end{document} [ R 1 ] + [ L 4 \u22c5 R 1 ] = [ R 1 ] T . On the other hand, decorin binds to CCR8, competing with CCL4 for CCR8 receptors , leading to reduced NF 21 , 29 \u03ba B activation: where  17 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[D]+[{R}_{2}]\\mathop{\\rightleftharpoons}\\limits_{{b}_{3}^{-}}^{{b}_{3}^{+}}[\\overline{D\\cdot {R}_{2}}],$$\\end{document} [ D ] + [ R 2 ] \u21cc b 3 \u2212 b 3 + [ D \u22c5 R 2 \u00af ] ,  is the association rate of decorin with CCR8 receptors and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 +  is the dissociation rate of the Decorin\u2013CCR8 complex, respectively. By invoking mass-action kinetics for all steps in the binding kinetics reactions in Eqs. ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 \u2212 14 )\u2013( 17 ), one can derive the following evolution equations for the intracellular variables  , [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}], [R_1]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] , [ R 1 ] R 2 ],  ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ]  in response to given decorin concentration [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] D ]: 18 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[\\overline{{L}_{4}\\cdot {R}_{1}}]}{dt}={b}_{1}^{+}[{L}_{4}][{R}_{1}]-{b}_{1}^{-}[\\overline{{L}_{4}\\cdot {R}_{1}}],$$\\end{document} d [ L 4 \u22c5 R 1 ] d t = b 1 + [ L 4 ] [ R 1 ] \u2212 b 1 \u2212 [ L 4 \u22c5 R 1 ] , 19 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[{R}_{1}]}{dt}=-{b}_{1}^{+}[{L}_{4}][{R}_{1}]+{b}_{1}^{-}[\\overline{{L}_{4}\\cdot {R}_{1}}],$$\\end{document} d [ R 1 ] d t = \u2212 b 1 + [ L 4 ] [ R 1 ] + b 1 \u2212 [ L 4 \u22c5 R 1 ] , 20 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[{R}_{2}]}{dt}=-{b}_{2}^{+}[{L}_{4}][{R}_{2}]+{b}_{2}^{-}[\\overline{{L}_{4}\\cdot {R}_{2}}]-{b}_{3}^{+}[D][{R}_{2}]+{b}_{3}^{-}[\\overline{D\\cdot {R}_{2}}],$$\\end{document} d [ R 2 ] d t = \u2212 b 2 + [ L 4 ] [ R 2 ] + b 2 \u2212 [ L 4 \u22c5 R 2 ] \u2212 b 3 + [ D ] [ R 2 ] + b 3 \u2212 [ D \u22c5 R 2 ] , 21 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[\\overline{{L}_{4}\\cdot {R}_{2}}]}{dt}={b}_{2}^{+}[{L}_{4}][{R}_{2}]-{b}_{2}^{-}[\\overline{{L}_{4}\\cdot {R}_{2}}],$$\\end{document} d [ L 4 \u22c5 R 2 ] d t = b 2 + [ L 4 ] [ R 2 ] \u2212 b 2 \u2212 [ L 4 \u22c5 R 2 ] , The detailed dynamics of the effects of decorin will be described in the section below. 22 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[\\overline{D\\cdot {R}_{2}}]}{dt}={b}_{3}^{+}[D][{R}_{2}]-{b}_{3}^{-}[\\overline{D\\cdot {R}_{2}}].$$\\end{document} d [ D \u22c5 R 2 ] d t = b 3 + [ D ] [ R 2 ] \u2212 b 3 \u2212 [ D \u22c5 R 2 ] . NF \u03ba B activation Basal activation of NF \u03ba B can occur through cytokine- and receptor-mediated pathways independent of the   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ]  axis. Specifically, pro-inflammatory cytokines, such as TNF- \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] \u03b1  and IL-1 120 \u2013 122 \u03b2 , or Toll-like receptor (TLR) 123 , 124  signaling, can activate the IKK complex, leading to NF 125 , 126 \u03ba B nuclear translocation. NF \u03ba B can be removed from the cellular system through various controllers, including primarily the I \u03ba B \u03b1 -mediated negative feedback unit, which rapidly sequesters NF \u03ba B in the cytoplasm and promotes its degradation, thereby restoring the basal level . Here and after, in order to model the activation of molecules, such as NF 127 , 128 \u03ba B from both the CCL4\u2013CCR5 complex and the CCL4\u2013CCR8 complex, we take switching forms with the Hill-type function. Both the CCL4\u2013CCR5 complex (  and the CCL4\u2013CCR8 complex  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] ) from receptor bindings \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ]  activate NF 14 \u2013 20 \u03ba B in microglia , leading to the governing equation of NF 21 \u2013 23 \u03ba B expression ([ F ]) where  23 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[F]}{dt}={\\lambda }_{F}+\\frac{{k}_{1}{[\\overline{{L}_{4}\\cdot {R}_{1}}]}^{l}}{{k}_{2}^{l}+{[\\overline{{L}_{4}\\cdot {R}_{1}}]}^{l}}+\\frac{{k}_{3}{[\\overline{{L}_{4}\\cdot {R}_{2}}]}^{l}}{{k}_{4}^{l}+{[\\overline{{L}_{4}\\cdot {R}_{2}}]}^{l}}-{\\mu }_{{\\rm{F}}}[F],$$\\end{document} d [ F ] d t = \u03bb F + k 1 [ L 4 \u22c5 R 1 ] l k 2 l + [ L 4 \u22c5 R 1 ] l + k 3 [ L 4 \u22c5 R 2 ] l k 4 l + [ L 4 \u22c5 R 2 ] l \u2212 \u03bc F [ F ] , \u03bb F  is the basal production rate of NF \u03ba B,  k 1  and  k 3  are the activation rates of  N F \u03ba B  by CCL4\u2013CCR5 and CCL4\u2013CCR8 complexes, respectively,  k 2 ,  k 4 ,  l  are the corresponding Hill type constants ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{2},{k}_{4}\\in {{\\mathbb{R}}}^{+}$$\\end{document} k 2 , k 4 \u2208 R + ) for activation of NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$l\\in {{\\mathbb{Z}}}^{+}$$\\end{document} l \u2208 Z + \u03ba B, and  \u03bc F  is the decay rate of NF \u03ba B. Microglia density (= M ( t )) The microglia population follows logistic growth with a growth rate  r M  and carrying capacity  M 0 . Thus, the governing equation of the microglia density is given by 24 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{dM}{dt}={r}_{M}M\\left(1-\\frac{M}{{M}_{0}}\\right).$$\\end{document} d M d t = r M M 1 \u2212 M M 0 . This system in Eqs. ( 18 )\u2013( 24 ) provides a comprehensive framework for understanding the interactions between CCL4, decorin, and their receptors (CCR5 and CCR8), as well as their roles in  N F \u03ba B  activation and macrophage dynamics. CCL4 concentration (=[ L 4 ]( t )) CCL4 is produced in T cells under the influence of the MDK\u2013LRP1 complex from the optic nerve  and binds to CCR5 9 \u2013 11  and CCR8 14 \u2013 17  receptors on microglia, forming ligand\u2013receptor complexes 18 \u2013 20 . These complexes subsequently induce the production of NF 9 , 12 , 13 \u03ba B in microglia . 21 \u2013 23 The mass balance equation for the CCL4 concentration is given by where  25 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[{L}_{4}]}{dt}={P}_{CCL4}+{B}_{CCL4},$$\\end{document} d [ L 4 ] d t = P C C L 4 + B C C L 4 , P CCL4  is the net production rate of CCL4 and  B CCL4  represents the ligand\u2013receptor binding reaction of CCL4\u2013CCR5 and CCL4\u2013CCR8 kinetics. Various cell types, including activated T cells (CD4+ and CD8+ T cells) and astrocytes, secrete CCL4 through pathways that are independent of midkine stimulation , providing the basal secretion of CCL4 in the model. Therefore, the basal production rate ( 9 , 21 \u03bb 4 ) and natural decay rate ( \u03bc 4 ) determine the basal level of CCL4 in the absence of production from MDK-mediated T cells. This provides a background concentration that allows NF \u03ba B activation dynamics to be sustained in the model. In our modeling framework, the CCL4 is produced from T cells in the presence of MDK activation in a nonlinear manner . While we take the same form of the Hill functions for switches for secretion of CCL4 from T cells, we take the multiplicative form of the Hill functions for both [MDK] and T cells to take into account the activation of the [MDK] action on CCL4 secretion only in the presence of T cells 9 \u2013 11 . Thus, the net production  21 P CCL4  consists of three components, basal production, T cell-mediated production and natural decay, as follows: where  26 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${P}_{CCL4}=\\mathop{\\underbrace{{\\lambda }_{4}}}\\limits_{\\mathrm{Source}}+\\mathop{\\underbrace{\\left(\\frac{{c}_{1}{[MDK]}^{m}}{{c}_{2}^{m}+{[MDK]}^{m}}\\right)\\left(\\frac{{c}_{3}{T}^{m}}{{c}_{4}^{m}+{T}^{m}}\\right)}}\\limits_{\\mathrm{Production}}-\\mathop{\\underbrace{{\\mu }_{4}[{L}_{4}]}}\\limits_{\\mathrm{Natural}\\,\\mathrm{Decay}},$$\\end{document} P C C L 4 = \u03bb 4 \u23df Source + c 1 [ M D K ] m c 2 m + [ M D K ] m c 3 T m c 4 m + T m \u23df Production \u2212 \u03bc 4 [ L 4 ] \u23df Natural Decay , c 1  is the activation rate of MDK and  c 3  is the rate of CCL4 production from T cells with Hill type coefficients  c 1 ,  c 2 ,  c 3 ,  c 4 ,  m  ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${c}_{1},{c}_{2},{c}_{3},{c}_{4}\\in {{\\mathbb{R}}}^{+}$$\\end{document} c 1 , c 2 , c 3 , c 4 \u2208 R + ). \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$m\\in {{\\mathbb{Z}}}^{+}$$\\end{document} m \u2208 Z + By taking into account the dynamics of CCL4 and its interaction with CCR5 and CCR8 receptors in the previous section, we have the following reaction terms: 27 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${B}_{CCL4}=-{b}_{1}^{+}[{L}_{4}][{R}_{1}]+{b}_{1}^{-}[\\overline{{L}_{4}\\cdot {R}_{1}}]-{b}_{2}^{+}[{L}_{4}][{R}_{2}]+{b}_{2}^{-}[\\overline{{L}_{4}\\cdot {R}_{2}}].$$\\end{document} B C C L 4 = \u2212 b 1 + [ L 4 ] [ R 1 ] + b 1 \u2212 [ L 4 \u22c5 R 1 ] \u2212 b 2 + [ L 4 ] [ R 2 ] + b 2 \u2212 [ L 4 \u22c5 R 2 ] . These Eqs. ( 26 ) and ( 27 ) represent the balance between the production, receptor interactions, and degradation of CCL4. While the production and decay of CCL4, thus stable status in the absence of perturbation (binding), is driven by the MDK in a nonlinear manner, the binding activities to CCR5 and CCR8 receptors regulate their availability and function. Combining the net production terms in Eq. ( 26 ) and the binding kinetics terms in Eq. ( 27 ) leads to the governing equations for the CCL4 concentration: 28 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{l}\\begin{array}{rcl}\\frac{d[{L}_{4}]}{dt} & = & {\\lambda }_{4}+\\left(\\frac{{c}_{1}{[MDK]}^{m}}{{c}_{2}^{m}+{[MDK]}^{m}}\\right)\\left(\\frac{{c}_{3}{T}^{m}}{{c}_{4}^{m}+{T}^{m}}\\right)-{\\mu }_{4}[{L}_{4}]-{b}_{1}^{+}[{L}_{4}][{R}_{1}]+{b}_{1}^{-}[\\overline{{L}_{4}\\cdot {R}_{1}}]\\\\ & & -{b}_{2}^{+}[{L}_{4}][{R}_{2}]+{b}_{2}^{-}[\\overline{{L}_{4}\\cdot {R}_{2}}]\\end{array}\\end{array}$$\\end{document} d [ L 4 ] d t = \u03bb 4 + c 1 [ M D K ] m c 2 m + [ M D K ] m c 3 T m c 4 m + T m \u2212 \u03bc 4 [ L 4 ] \u2212 b 1 + [ L 4 ] [ R 1 ] + b 1 \u2212 [ L 4 \u22c5 R 1 \u00af ] \u2212 b 2 + [ L 4 ] [ R 2 ] + b 2 \u2212 [ L 4 \u22c5 R 2 \u00af ] Densities of T cells (= T ( t ),  T a ( t )) and Decorin concentration (=[ D ]( t )) Recent experimental studies have demonstrated that T cells can undergo phenotypic reprogramming depending on the surrounding microenvironment, and this process is reversible under certain biological conditions. T cell phenotype change is a fundamental process where T cells undergo molecular changes on surface proteins and functions in response to external stimuli, leading to different cell types like naive effector, or memory T cells . T cells are reprogrammed under an asthma-mediated environment (e.g., decorin), transiting to activated T cells, but removal of the original source (asthma) levels back to glioma-promoting phenotype 129 \u2013 131 . Therefore, we consider two distinct T cell types: one that induces CCL4 production in response to midkine stimulation 26 , 132 , and another that is reprogrammed by asthma-associated signaling to secrete decorin 9 , 21 . 21 Two types of T cells are considered in this framework: (i) regular T cells ( T ) and (ii) reprogrammed T cells induced by asthma ( T a ). The evolution of the densities of both types of T cells follows governing equations similar to those for microglia, but with the following assumptions: (i) The naive T cells maintain their circulating population of carrying capacity  T 0  by following the logistic growth at an intrinsic rate  r T ; (ii) The naive T cells transform into the active re-programmed T cells at the rate  \u03bb T  in response to asthma ( I asthma  = 1); (iii) The active re-programmed T cells transform into the regular T cells at the rate  \u03bb T1  in the absence of asthma ( I asthma  = 0); (iv) The re-programmed T cells disappear from the system at the decay rate  \u03bc a ; (v) External re-programmed T cells can be injected at  u T ( t ) for therapeutic purposes. Thus, two transition parameters  \u03bb T ,  \u03bb T1  control the phenotypic transition between regular T cells and re-programmed T cells in response to asthma symptoms. This leads to following evolution equations: 29 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{dT}{dt}={r}_{T}T\\left(1-\\frac{T}{{T}_{0}}\\right)-{\\lambda }_{T}T{I}_{asthma}+{\\lambda }_{T{1}}{T}_{a}\\left(1-{I}_{asthma}\\right),$$\\end{document} d T d t = r T T 1 \u2212 T T 0 \u2212 \u03bb T T I a s t h m a + \u03bb T 1 T a 1 \u2212 I a s t h m a , Here, the indicator function  30 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d{T}_{a}}{dt}={u}_{T}(t)+{\\lambda }_{{T}}T{I}_{asthma}-{\\lambda }_{{T}{1}}{T}_{a}(1-{I}_{asthma})-{\\mu }_{{\\rm{a}}}{T}_{{\\rm{a}}}.$$\\end{document} d T a d t = u T ( t ) + \u03bb T T I a s t h m a \u2212 \u03bb T 1 T a ( 1 \u2212 I a s t h m a ) \u2212 \u03bc a T a . I asthma ( \u22c5 ) is given by 31 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{l}{I}_{asthma}(\\cdot )=\\left\\{\\begin{array}{cc}1 & \\mathrm{ashtma}\\\\ 0 & \\mathrm{otherwise}.\\end{array}\\right.\\end{array}$$\\end{document} I a s t h m a ( \u22c5 ) = 1 ashtma 0 otherwise . Decorin is an important regulator of NF \u03ba B by interfering with the CCL4\u2013CCR8 binding on microglia through the formation of the decorin\u2013CCR8 complex in Eq. ( 17 ). Decorin is secreted by reprogrammed T cells  and decays at a rate  21 \u03bc D . By taking into account these and the binding kinetics in Eq. ( 17 ), we have the following governing equation of decorin: 32 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[D]}{dt}={\\lambda }_{{T}_{a}}{T}_{a}-{b}_{3}^{+}[D][{R}_{2}]+{b}_{3}^{-}[\\overline{D\\cdot {R}_{2}}]-{\\mu }_{D}[D].$$\\end{document} d [ D ] d t = \u03bb T a T a \u2212 b 3 + [ D ] [ R 2 ] + b 3 \u2212 [ D \u22c5 R 2 ] \u2212 \u03bc D [ D ] . CCL5 concentration ( = [ L 5 ]( t )) CCL5 is an optic glioma mitogen known to promote the growth of optic glioma . CCL5 is produced and expressed via NF 60 , 133 \u03ba B activation by microglia . Thus, activation of NF 21 , 134 , 135 \u03ba B on microglia by decorin is crucial in the onset of optic glioma . While we take the same form of the Hill functions for switches for secretion of CCL5 from microglia, we take the multiplicative form of the Hill functions for both NF 21 \u03ba B and microglia to take into account the activation of the NF \u03ba B action on CCL5 secretion only in the presence of microglia . Taking this into account as well as natural decay, we get the governing equation of CCL5 concentration ([ 21 L 5 ]): where  33 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d[{L}_{5}]}{dt}={k}_{5}\\left(\\frac{{[F]}^{n}}{{k}_{6}^{n}+{[F]}^{n}}\\right)\\left(\\frac{{M}^{n}}{{k}_{8}^{n}+{M}^{n}}\\right)-{\\mu }_{5}[{L}_{5}].$$\\end{document} d [ L 5 ] d t = k 5 [ F ] n k 6 n + [ F ] n M n k 8 n + M n \u2212 \u03bc 5 [ L 5 ] . k 5  is the production rate of CCL5 by microglia in the presence of NF \u03ba B activation signal,  k 6 ,  k 8 ,  n  are the Hill type constant ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{6},{k}_{8}\\in {{\\mathbb{R}}}^{+}$$\\end{document} k 6 , k 8 \u2208 R + ), and finally,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n\\in {{\\mathbb{Z}}}^{+}$$\\end{document} n \u2208 Z + \u03bc 5  is decay rate of CCL5. Cancer cell density ( =  C ( t )) Growth of optic glioma was modeled using a nonlinear logistic growth equation. Asthma-induced T cells modulate the immune environment, affecting proliferation of optic glioma cells through Decorin\u2013CCL4\u2013CCR 5,8 \u2013NF \u03ba B signaling network on microglia and up- or down-regulation of CCL5 . Thus, the growth rate depends on CCL5 concentration ([ 21 L 5 ]) as experimentally observed . The governing equation of cancer cell density ( 21 C ) is given by where  34 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{dC}{d{\\rm{t}}}=r\\left(1+\\frac{{k}_{9}{[{L}_{5}]}^{n}}{{k}_{10}^{n}+{[{L}_{5}]}^{n}}\\right)C\\left(1-\\frac{C}{{C}_{0}}\\right),$$\\end{document} d C d t = r 1 + k 9 [ L 5 ] n k 10 n + [ L 5 ] n C 1 \u2212 C C 0 , r  is the intrinsic growth rate of cancer cells,  k 9  is the enhancement rate of cancer cell growth by CCL5 with a Hill coefficients  n  and michaelis constant  k 10 , and finally  C 0  is the carrying capacity of the cancer cells. The model parameters are provided in Table  1 . Parameter estimation in the governing Eqs. ( 14 )\u2013( 34 ) and additional Eqs. ( 1 )\u2013( 13 ) are given in  Supplementary information . All simulations in this study were conducted using MATLAB (MathWorks) with the  o d e 15 s  solver, which employs variable-step, variable-order numerical schemes optimized for stiff chemical reaction networks. The reference values and initial conditions are provided in Tables  2  and  3 . Table 2 Reference values in the model Variable Description Values Refs t * Time 1\u2009h \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${[{A}_{0}]}^{* }$$\\end{document} [ A 0 ] * Concentration of intracellular system 50\u2009nM 16 , 21 , 167 T * Density of T cells 1.0 \u00d7 10 \u22124 \u2009g/cm 3 155 , 156 [ F ] * Concentration of NF \u03ba B 400\u2009nM 145 \u2013 148 M * Density of microglia 4.0 \u00d7 10 \u22125 \u2009g/cm 3 149 , 150 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${[{L}_{5}]}^{* }$$\\end{document} [ L 5 ] * Concentration of CCL5 70\u2009nM 16 , 21 , 167 C * Density of optic glioma cells 4.0 \u00d7 10 \u22125 \u2009g/cm 3 149 , 150 , 165 , 166 The star indicates the reference value of given variable. These values were used to nondimensionalize the whole mathematical equations so that we can have dimensionless variables. This nondimensionalization was provided in Supplementary information. Table 3 Initial conditions Variable Description Initial condition Refs. [ L 4 ] CCL4 concentration 0\u2009\u03bcM 168 [ R 1 ] CCR5 concentration 5 \u00d7 10 \u22122 \u2009\u03bcM 169 [ R 2 ] CCR8 concentration 5 \u00d7 10 \u22122 \u2009\u03bcM 169 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] CCL4\u2013CCR5 complex concentration 0\u2009\u03bcM 168 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] CCL4\u2013CCR8 complex concentration 0\u2009\u03bcM 168 [ D ] Decorin concentration 0\u2009\u03bcM 168 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{1}}]$$\\end{document} [ D \u22c5 R 1 \u00af ] Decorin\u2013CCR5 complex concentration 0\u2009\u03bcM 168 T T cells density 1 \u00d7 10 \u22125 \u2009g/cm 3 155 , 156 T a re-programming T cells density 0\u2009g/cm 3 155 , 156 [ F ] NF \u03ba B concentration 0\u2009\u03bcM 168 M Microglia density 3 \u00d7 10 \u22125 \u2009\u03bcM 149 , 150 [ L 5 ] CCL5 concentration 0\u2009\u03bcM 168 I IL-2 concentration 0\u2009IU/ml 168 C Optic glioma cells density 4 \u00d7 10 \u22126 \u2009g/cm 3 149 , 150 , 165 , 166",
  "cache_level": "full",
  "has_fulltext": true,
  "fetch_date": "2026-02-19 09:31:37",
  "introduction": "Introduction Optic glioma is a low-grade astrocytic tumor that arises primarily within the optic nerve, frequently in pediatric populations, and is strongly associated with neurofibromatosis type 1 (NF1) mutations . This tumor type, although histologically benign, poses significant clinical concerns due to potential progressive vision loss and hypothalamic dysfunction. A hallmark of NF1-associated optic glioma is the hyperactivation of RAS signaling, caused by loss-of-function mutations in the NF1 gene, which encodes neurofibromin, a negative regulator of RAS-GTP 1 \u2013 4 . This molecular dysregulation contributes not only to tumor cell proliferation but also to broader alterations in the tumor microenvironment (TME), fostering biochemical conditions that promote immune cell recruitment, chronic inflammation, and tumor progression. Among the key factors influencing this microenvironment is midkine (MDK), a heparin-binding growth factor highly expressed in response to RAS activation 5 \u2013 8 . 9 \u2013 11 MDK is secreted from the optic nerve and has been shown to exert profound immunomodulatory effects . It reshapes the phenotype of infiltrating T cells within the TME, leading to secretion of CCL4, a chemokine that plays a pivotal role in orchestrating immune\u2013glial interactions 9 \u2013 11 . Once released, CCL4 interacts with the microglial surface receptors, CCR5 9 , 12 , 13  and CCR8 14 \u2013 17 , forming ligand\u2013receptor complexes that serve as an upstream activator of the nuclear factor kappa B (NF 18 \u2013 20 \u03ba B) signaling pathway . This particular pathway is widely recognized for its role in inflammation and cancer progression, and its activation culminates in the production of CCL5, a potent chemokine that fosters tumor growth by enhancing cell proliferation, migration, and immune evasion mechanisms 21 \u2013 23 . As a result, the midkine\u2013T cell\u2013CCL4\u2013microglia\u2013NF 21 , 22 , 24 , 25 \u03ba B\u2013CCL5 axis forms a central pro-tumorigenic feedback loop within the optic glioma microenvironment. Emerging studies suggest that environmental and inflammatory conditions, such as asthma , can significantly alter immune cell function within the TME. Asthma is known to induce widespread immune remodeling, including the reprogramming of CD8 21 +  T cells, which acquire non-cytotoxic, regulatory-like phenotypes . In the optic glioma, asthma-induced, reprogrammed T cells (re-T cells) were shown to inhibit tumor growth by secreting decorin, a small leucine-rich proteoglycan with established anti-tumor properties 21 , 22 , 26 . Decorin is known to interact with various components of the extracellular matrix (ECM) and cell surface receptors, overcoming the ECM barrier in oncolytic virus (OV) therapy 22 , 27  and interfering with CCR8-mediated signaling 28  in the TME. Decorin can inhibit the formation of the CCL4\u2013CCR8 complexes on microglia by competing with CCL4 in binding to CCR8 21 , 29 , which leads to suppression of CCL5 induction by the downstream NF 21 , 29 \u03ba B pathway, and eventually to attenuation of the tumor-promoting microenvironment . This intriguing observation of indirect suppression of tumor growth through immune reprogramming rather than direct cytotoxic effects suggests a novel organ\u2013organ control mechanism by which systemic inflammation and immune history, such as asthma, may influence glioma dynamics 30 \u2013 32 , putting decorin on the list of promising avenues for therapeutic exploration in brain tumors. Despite these emerging insights, the full implications of the MDK\u2013CCL4\u2013CCR5/CCR8\u2013NF 9 , 21 , 33 , 34 \u03ba B\u2013CCL5 axis, and its regulation by asthma-reprogrammed T cells, remain poorly understood. In this work, we employed the framework of a differential equation model to account for the role of asthma-reprogrammed T cells and decorin in the regulation of the optic glioma microenvironment and tumor growth. Based on the schematic diagram in Fig.  1 , the model consists of a system of ordinary and delay differential equations involving the following variables: [ R 1 ]( t )\u2009=\u2009Concentration of CCR5 at time  t , [ ]( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{{L}_{4}\\cdot {R}_{1}}$$\\end{document} L 4 \u22c5 R 1 \u00af t )\u2009=\u2009Concentration of the CCL4\u2013CCR5 complex at time  t , [ R 2 ]( t )\u2009=\u2009Concentration of CCR8 at time  t , [ ]( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{{L}_{4}\\cdot {R}_{2}}$$\\end{document} L 4 \u22c5 R 2 \u00af t )\u2009=\u2009Concentration of the CCL4\u2013CCR8 complex at time  t , [ L 4 ]( t )\u2009=\u2009Concentration of CCL4 at time  t , [ D ]( t )\u2009=\u2009Concentration of decorin at time  t , [ ]( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{D\\cdot {R}_{2}}$$\\end{document} D \u22c5 R 2 \u00af t )\u2009=\u2009Concentration of the decorin\u2013CCR8 complex at time  t , [ F ]( t )\u2009=\u2009Concentration of NF \u03ba B at time  t , [ L 5 ]( t )\u2009=\u2009Concentration of CCL5 at time  t , M ( t )\u2009=\u2009Density of microglia at time  t , T ( t )\u2009=\u2009Density of T cells at time  t , T ( a t )\u2009=\u2009Density of re-programming T cells at time  t , C ( t )\u2009=\u2009Density of optic glioma cells at time  t . Fig. 1 Schematic diagram of the optic glioma microenvironment and key regulatory pathways . 21 NF1 mutations disrupt RAS signaling, leading to midkine production, while increased expression of decorin on asthma-induced T cells inhibits activation of NF \u03ba B by interfering with CCL4\u2013CCR8 receptor binding on microglia. Down-regulated NF \u03ba B leads to a reduction in CCL5 production, a key driver of tumor growth. This model is then used to: (i) investigate how asthma-induced T cell reprogramming influences the production of decorin and its subsequent inhibitory effects on CCR8, (ii) analyze how the balance between tumor-promoting (CCL5-mediated) and tumor-suppressive (decorin-mediated) pathways impacts glioma growth dynamics, and (iii) develop optimal therapeutic strategies targeting decorin production and CCR8 inhibition to suppress glioma progression effectively. Our work is to incorporate decorin-mediated control of CCL4\u2013CCR5/8-NF \u03ba B\u2013CCL5 intracellular mechanism into a quantitative mathematical framework linking asthma-reprogrammed T-cell signaling to glioma growth dynamics, which leads to a comprehensive understanding of the whole immune assembly and processes with consistent, experimental validation. We show that the mathematical model can reproduce the empirical observations, and we make several predictions as to how various therapeutic interventions can prevent the onset of optic glioma.",
  "results": "Results Core control system in the absence of asthma Midkine is a neurotrophic growth factor  that plays a crucial role in promoting optic glioma growth by inducing CCL4 expression in T cells, which in turn elevates CCL5 levels on microglia, a key driver of tumor progression. Figure  35 2  shows comprehensive changes of those key molecules ([ L 4 ],  ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] , [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] L 5 ]) as the midkine level is changed. Figure  2 A, D show the dose\u2013response curves of [CCL4] (Fig.  2 A) and [CCL5] (Fig.  2 D) levels for various midkine stimuli. Since midkine directly induces CCL4 production in T cells, a specific range of the midkine level is required for CCL4 expression. The quantitative analysis of the mathematical model shows that the predicted CCL4 expression aligns with observed experiments  for various midkine input values (Fig.  21 2 B; [ MDK ] = 0, 1.66, 3.33, 6.67\u2009\u03bcM) and an increase in CCL4 levels lead to up-regulated receptor complexes ([ C C L 4 \u22c5  C C R 5] (blue) and [ C C L 4 \u22c5  C C R 8] (red)) in binding kinetics (Fig.  2 C) and up-regulation of CCL5 (Fig.  2 D) on microglia by activation of NF \u03ba B (Fig.  1 ). Figure  2 E illustrates the positive correlation between CCL4 and CCL5 and up-regulation of both key input\u2013output variables on microglia as midkine levels increase. This down- and up-regulation of CCL5 levels in response to low and high CCL4 stimuli was well quantified in experiments  and predicted in the mathematical model (Fig.  21 2 F). Fig. 2 Effect of midkine on intracellular dynamics of T cells and microglia. A  Steady state of [CCL4] in response to high and low midkine levels.  B  Changes in [CCL4] levels in response to various midkine concentrations ([MDK]\u2009=\u20090, 1.66, 3.33, 6.67\u2009\u03bcM): model (blue) and experiments (red; ).  21 C  Levels of the CCL4-complex ([CCL4\u2013CCR5] (blue) and [CCL4\u2013CCR8](red)) in the system in response to various midkine concentrations ([MDK]\u2009=\u20090, 1.66, 3.33, 6.67\u2009\u03bcM). Steady states of [CCL5] in response to various midkine levels ( D ) and corresponding SS correlation between CCL4 and CCL5 levels in the  L 4 \u2212 L 5  phase plane ( E ).  F  Comparison with experimental data: [CCL5] levels in the system in response to the low (left) and high (right) of CCL4 levels: simulation (blue) and experiments (red) . 21 The delicate control of the intracellular system of [CCL4\u22c5CCR5] and [CCL4\u22c5CCR8] is necessary for the stable onset of tumor growth or maintenance of anti-tumorigenic mediation of microglia in a given immune\u2013tumor interaction system. In Fig.  3 , we investigate the effect of the binding rates of CCL4\u2013CCR5 complex on the system\u2019s dynamics, especially CCL5 expression, a key driver of optic glioma progression. Since CCL5 is primarily regulated by the activation of NF \u03ba B, we explore how modifications in binding and dissociation rates affect the formation of CCL4\u2013CCR5 complexes and their downstream effectors, thus regulating the onset of tumor formation. Figure  3 A shows the CCL5 level for various association rates ( ) and midkine levels. Since midkine plays a crucial role in inducing CCL4 production in T cells, its presence indirectly regulates CCL5 expression through the CCL4\u2013CCR5\u2013NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + \u03ba B axis. While the higher   and higher midkine levels lead to the up-regulation of CCL5, the lower  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 +  and midkine levels inhibit CCL5 secretion from microglia. For a fixed  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + , an increase in the midkine leads to up-regulation of the CCL4\u2013CCR5 complex (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + 2 C), enhancing NF \u03ba B activation and CCL5 production (Fig.  3 A, B). As   is decreased from the base value ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + ), [CCL4\u2013CCR5] complex level (blue, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}=12\\to 1.2$$\\end{document} b 1 + = 12 \u2192 1 . 2 2 C, E), NF \u03ba B expression (blue; Fig.  2 F), and CCL5 production (blue, Fig.  2 B) are significantly decreased even for high midkine levels, delaying the onset of tumor progression. On the other hand, an increase in   from the base value ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + ) leads to up-regulation of the [CCL4\u2013CCR5] complex (blue, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}=12\\to 120$$\\end{document} b 1 + = 12 \u2192 120 3 C, E) and elevation in the NF \u03ba B activation (blue, Fig.  3 D, F) even at lower midkine levels. Consequently, this significantly enhances the expression of CCL5, promoting tumor progression. Because of the separate topological structure of the receptor binding networks among CCL4\u2013CCR5 and CCL4\u2013CCR8, the changes in   do not affect the CCL4\u2013CCR8 dynamics regardless of midkine concentrations (red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + 3 C, E). Figure  3 G shows the CCL5 level for various dissociation rates ( ) and midkine concentrations. While the lower  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 -  and higher midkine levels elevate CCL5 production, the higher  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 -  and lower midkine levels suppress CCL5 secretion from microglia. For example, in the absence of midkine, an increase in  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - , the dissociation rate of the CCL4\u2013CCR5 complexes, results in faster breakdown of the CCL4\u2013CCR5 complex (blue, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - 3 I) and deactivation of NF \u03ba B (blue, Fig.  3 J), leading to lower CCL5 secretion (red, Fig.  3 J). Even when the midkine level is high, the rapid dissociation of CCL4\u2013CCR5 complexes ( ) prevents sustained NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}=0.18\\to 1.8$$\\end{document} b 1 - = 0 . 18 \u2192 1 . 8 \u03ba B activation (blue, Fig.  3 K), thereby suppressing CCL5 production (Fig.  3 H, L). In those cases, the CCL4\u2013CCR8 complex level remains constant due to the network structure. These results suggest that a strategy of either increasing the dissociation rate or decreasing the association rate may serve as an anti-cancer potential to attenuate CCL5-mediated tumor progression by destabilizing CCL4\u2013CCR5 interactions. Fig. 3 Effect of the association ( ) and dissociation ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + ) rates of CCL4\u2013CCR5 binding on the intracellular dynamics of microglia and tumor growth. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - A  CCL5 level for various midkine concentrations and association rates ( ).  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + B  CCL5 levels for various midkine concentrations when   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}=1.2,12,120$$\\end{document} b 1 + = 1 . 2 , 12 , 120  fixed. Changes in the [CCL4\u2013CCR5] and [CCL4\u2013CCR8] complex levels ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}=0.18$$\\end{document} b 1 - = 0 . 18 C ) and NF \u03ba B/CCL5 ( D ) as   is increased in the absence of midkine.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + E ,  F  Same as in  C ,  D  in response to the high midkine concentration.  G  CCL5 levels for various midkine concentrations and dissociation rates ( ).  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - H  CCL5 levels for various midkine concentrations when   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}=0.018,0.18,1.8$$\\end{document} b 1 - = 0 . 018 , 0 . 18 , 1 . 8  fixed. Changes in the [CCL4\u2013CCR5] and [CCL4\u2013CCR8] complex levels ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}=12$$\\end{document} b 1 + = 12 I ) and NF \u03ba B/CCL5 ( J ) as   is increased in the absence of midkine.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - K ,  L  Same as in  I ,  J  in response to the high midkine concentrations. Figure  4 A shows time courses of concentrations of CCR5 ([ R 1 ], solid) and CCL4\u2013CCR5 complex ( , dotted) in response to high ([ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] L 4 ] = 50\u2009nM) and low ([ L 4 ] = 0.1\u2009nM) CCL4 stimuli. The dynamic changes in the CCR8 ([ R 2 ], solid) and CCL4\u2013CCR8 complex ( , dotted) in the neighboring pathway for the same CCL4 input are shown in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] 4 B. The initial condition was  . While a high (normal) CCL4 expression by microglia induces aggressive growth of an optic glioma by forming the CCL4\u2013CCR5 and CCL4\u2013CCR8 complexes and up-regulation of NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{R}_{1}](0)=50,[\\overline{{L}_{4}\\cdot {R}_{1}}]=0,[\\overline{{L}_{4}\\cdot {R}_{2}}]=0$$\\end{document} [ R 1 ] ( 0 ) = 50 , [ L 4 \u22c5 R 1 \u00af ] = 0 , [ L 4 \u22c5 R 2 \u00af ] = 0 \u03ba B and CCL5 in microglia, either low levels of CCL4 or strong decorin expression from re-programmed T cells in TME from asthma do not support the onset of this form of glioma. Figure  4 C shows the response to CCL4 in the core control system for various CCL4 levels ( L 4 \u2009=\u20090, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200\u2009nM). An increase in CCL4 levels promotes ligand binding activity in both CCL4\u2013CCR5 and CCL4\u2013CCR8 receptor systems. This transient activation of CCL4\u2013CCR5/CCL4\u2013CCR8 receptor binding and subsequent secretion of CCL5 (blue dashed in Fig.  4 F) are in agreement with experimental data  (Fig.  7 2 F). In Fig.  4 E, we investigate key binding activities in two receptor channels in response to a fluctuating CCL4 input expression level (Fig.  4 D) over the range of 0\u201320\u2009nM:  . Given a fluctuating CCL4 environment, the CCL4\u2013CCR5 (red solid curves in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}](t)=\\,10\\cos (\\pi t/240)+10$$\\end{document} [ L 4 ] ( t ) = 10 cos ( \u03c0 t / 240 ) + 10 4 E) and CCL4\u2013CCR8 (blue dashed curves in Fig.  4 E) complexes fluctuate between high and low states. For instance, as the CCL4 input decreases, the high level of the initial CCL4-complexes binding activities is reduced, entering a zone of low tumor growth rates by suppressing NF \u03ba B (red curves in Fig.  4 F), CCL5 secretion (blue dashed curves Fig.  4 F), and essentially inducing the phenotypic transition from the  on  state (pink box in Fig.  4 G) to the  off  state (blue box in Fig.  4 G) of tumor growth. When the CCL4 level is increased again after  t  = 240\u2009h, the binding activity is enhanced again (Fig.  4 E), and the system exits the  off  state (blue \u2192 red box in Fig.  4 G) by activating NF \u03ba B (red curves in Fig.  4 F) and promoting CCL5 secretion (blue dashed in Fig.  4 F) by microglia. Fig. 4 Dynamics of the CCL4\u2013CCR5/CCL4\u2013CCR8 binding and optic glioma growth in response to CCL4 fluctuation. Time courses of concentrations of CCR5/CCL4\u2013CCR5 complex ( A ) and CCR8/CCL4\u2013CCR8 complex ( B ) in response to high ([ L 4 ] = 50\u2009nM) and low ([ L 4 ] = 0.1\u2009nM) CCL4 stimuli.  C  Binding response to CCL4 in the core control system. Time courses of CCL4-CCR5 (red solid,  E ) and CCL4-CCR8 (blue dashed,  E ) binding activity in response to a fluctuating CCL4 input ( D ):  .  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}](t)=10\\cos (\\pi t/240)+10$$\\end{document} [ L 4 ] ( t ) = 10 cos ( \u03c0 t / 240 ) + 10 F  Time courses of the NF \u03ba B (red solid) and CCL5 (blue dashed) under  L 4 ( t ) in ( D ).  G  Time courses of the cancer cell density under  L 4 ( t ) in ( D ). Given fluctuating CCL4 environment (Fig.  4 D), different relative ratios of the dissociation to association in the CCL4\u2013CCR5 pathway ( ) induce three types of formation of the CCL4\u2013CCR5 complex (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}5}=0.15,\\,15\\,){\\rm{e}}{\\rm{s}}{\\rm{a}}{\\rm{b}}(\\,,\\,1500\\,{\\rm{nM}}$$\\end{document} K D CCR 5 = 0.15 , 15 ) e s a b ( , 1500 nM 5 A): static high level (blue dashed), fluctuation between high and low states (red solid), or sustained low level (black dotted). For instance, with the ratio  , as the CCL4 input decreases (blue solid in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}5}$$\\end{document} K D CCR 5 4 D), the high level of initial CCL4\u2013CCR5 binding activities is reduced (red, Fig.  5 A), entering a zone of low tumor growth rates ( t  \u2208 [150, 350] in Fig.  5 C) by suppressing NF \u03ba B (red, middle column in Fig.  5 B), CCL5 secretion (blue, middle column in Fig.  5 B), and essentially inducing the phenotypic transition from the  on  state to the  off  state of tumor growth. When the CCL4 level is increased again after  t  = 240\u2009h, the binding activity is enhanced again (red, Fig.  5 A) and the system exits the  off  state (red, Fig.  5 C) by activating NF \u03ba B (red, Fig.  5 B) and promoting CCL5 secretion (blue, Fig.  5 B) by microglia. When   is small (=0.15\u2009nM), the intracellular system induces a high level of CCL4\u2013CCR5 binding (blue dashed, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}5}$$\\end{document} K D CCR 5 5 A), maintaining up-regulation of NF \u03ba B and CCL5 (left column in Fig.  5 B), and thus leading to active tumor growth without entering the suppression zone (blue dashed, Fig.  5 C) in spite of the fluctuating CCL4 levels. When   is large (=1500\u2009nM), the binding activity of CCL4\u2013CCR5 is significantly reduced (black dotted, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}5}$$\\end{document} K D CCR 5 5 A) in response to fluctuation between the high and low CCL4 levels, leading to down-regulation of NF \u03ba B and CCL5 (right column in Fig.  5 B), leading to constant suppression of tumor growth (black dotted, Fig.  5 C). In a similar fashion, different binding ratios in the CCL4\u2013CCR8 pathway ( ) induce the same three modes of formation of the CCL4\u2013CCR8 complex (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}8}=0.1,\\,10\\,){\\rm{e}}{\\rm{s}}{\\rm{a}}{\\rm{b}}(\\,,\\,1000\\,{\\rm{nM}}$$\\end{document} K D CCR 8 = 0.1 , 10 ) e s a b ( , 1000 nM 5 D), the level of NF \u03ba B and CCL5 (Fig.  5 E), and cancer cell population (Fig.  5 F). Figure  5 G illustrates phenotypic changes in response to the various dissociation constants (  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}5}$$\\end{document} K D CCR 5 ). As dissociation constants are increased, the TME selects the frequent temporal immune transitions in preference to all time  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}8}$$\\end{document} K D CCR 8 -mode regardless of CCL4 fluctuation. Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{a}$$\\end{document} P a 5 H, I shows the time courses of concentrations of NF \u03ba B (Fig.  5 H) and cancer cell population (Fig.  5 I) in response to the same continuous temporal profile of CCL4 in Fig.  4 D for various binding ratio sets  . For the base case  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$({K}_{{\\rm{D}}}^{{\\rm{CCR}}5},{K}_{{\\rm{D}}}^{{\\rm{CCR}}8})=(0.15,0.1),\\,(15,10),\\,(1500,1000)$$\\end{document} ( K D CCR 5 , K D CCR 8 ) = ( 0.15 , 0.1 ) , ( 15 , 10 ) , ( 1500 , 1000 ) , a high\u2013low\u2013high fluctuation of CCL4 leads to a cycle of growth-suppression-growth in optic glioma (red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$({K}_{{\\rm{D}}}^{{\\rm{CCR}}5},{K}_{{\\rm{D}}}^{{\\rm{CCR}}8})=(15,10)$$\\end{document} ( K D CCR 5 , K D CCR 8 ) = ( 15 , 10 ) 5 I) via the same regulation of CCL4\u2013CCR5\u2013CCR8\u2013NF\u03baB\u2013CCL5 signaling as in Fig.  5 A\u2013F above. As the ratio is lower than the base values, the static high levels of NF \u03ba B (blue dashed, Fig.  5 H) and CCL5 from sustained receptor complexed ( ) induce a continuous high growth rate (blue dashed, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}],[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] , [ L 4 \u22c5 R 2 \u00af ] 5 I), while as increase in these ratios induces a continuous low growth rate (black dotted, Fig.  5 I) via the down-regulation NF \u03ba B and CCL5 (black dotted, Fig.  5 H). Fig. 5 Dynamics of the CCL4\u2013CCR5/CCL4\u2013CCR8 binding and optic glioma growth for various dissociation constants in response to CCL4 fluctuation. Time courses of CCL4\u2013CCR5 binding activity ( A ), levels of NF \u03ba B and CCL5 at  t  = 240\u2009h (comb) and 480\u2009h (filled) ( B ), and time courses of cancer cell population ( C ) for various binding ratios   in response to a fluctuating CCL4 input Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}5}={b}_{1}^{-}/{b}_{1}^{+}=0.15,\\,15\\,){\\rm{e}}{\\rm{s}}{\\rm{a}}{\\rm{b}}(\\,,\\,1500\\,{\\rm{nM}}$$\\end{document} K D CCR 5 = b 1 \u2212 / b 1 + = 0.15 , 15 ) e s a b ( , 1500 nM 4 D. Time courses of CCL4\u2013CCR8 binding activity ( D ), levels of NF \u03ba B and CCL5 at  t  = 240\u2009h (comb) and 480\u2009h (filled) ( E ), and time courses of cancer cell population ( F ) for various binding ratios   in response to a fluctuating CCL4 input Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}8}={b}_{2}^{-}/{b}_{2}^{+}=0.1,\\,10\\,){\\rm{e}}{\\rm{s}}{\\rm{a}}{\\rm{b}}(\\,,\\,1000\\,{\\rm{nM}}$$\\end{document} K D CCR 8 = b 2 \u2212 / b 2 + = 0.1 , 10 ) e s a b ( , 1000 nM 4 D.  G  The corresponding phenotypic transitions between   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{a}$$\\end{document} P a  modes when dissociation constants ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{t}$$\\end{document} P t ) are varied.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{CCR}}5},\\,{K}_{{\\rm{D}}}^{{\\rm{CCR}}8}$$\\end{document} K D CCR 5 , K D CCR 8 H ,  I  time courses of NF \u03ba B levels and cancer cell population for various binding ratios in both CCL4\u2013CCR5 and CCL4\u2013CCR8 pathways:  . \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$({K}_{{\\rm{D}}}^{{\\rm{CCR}}5},{K}_{{\\rm{D}}}^{{\\rm{CCR}}8})=(0.15,0.1),\\,(15,10),\\,(1500,1000)$$\\end{document} ( K D CCR 5 , K D CCR 8 ) = ( 0.15 , 0.1 ) , ( 15 , 10 ) , ( 1500 , 1000 ) Figure  6 A shows the CCL5 level for various association rates ( ) and midkine levels in the intracellular system of microglia. While the higher  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 +  and higher midkine expression lead to the up-regulation of CCL5, the lower  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 +  and midkine input suppress CCL5 production from microglia. For a fixed  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + , an increase in the midkine level leads to up-regulation of the CCL4\u2013CCR8 complex (red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + 2 C), promoting NF \u03ba B activation and CCL5 production (Fig.  6 A, B). A decrease in   from the base value ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + ) induces suppression of both the [CCL4\u2013CCR8] complex level (red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}=12\\to 1.2$$\\end{document} b 2 + = 12 \u2192 1 . 2 6 C, E), and CCL5 expression (red, Fig.  6 B, D, and F), delaying the onset of tumor progression. On the other hand, an increase in   from the base value ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + ) leads to significant escalation of the [CCL4\u2013CCR8] complex formation (blue, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}=12\\to 120$$\\end{document} b 2 + = 12 \u2192 120 6 C, E) and elevation of NF \u03ba B levels (blue, Fig.  6 D, F) even at lower midkine concentrations, enhancing the expression level of CCL5 (red, Fig.  6 D, F). Thus, enhanced association strength of the [CCL4\u2013CCR8] complex will promote tumor even in the absence of midkine. Figure  6 G shows the CCL5 level for various dissociation rates ( ) and midkine levels. While the lower  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 -  and higher midkine input promotes CCL5 secretion, the larger  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 -  and lower midkine stimulus suppresses CCL5 expression on microglia. Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - 6 H shows steady state values of CCL5 in response to various midkine levels for ( ) when  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}=0.012,0.12,1.2$$\\end{document} b 2 - = 0 . 012 , 0 . 12 , 1 . 2  is fixed ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + ). The overall shape of the switching curve of CCL5 moves down (or up) as  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}=12$$\\end{document} b 2 + = 12  increases (or decreases), changing the probability of CCL5-mediated tumor growth. For example, an increase in  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 -  ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - ) leads to faster dissociation of the CCL4\u2013CCR8 complex (red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}=0.12\\to 1.2$$\\end{document} b 2 - = 0 . 12 \u2192 1 . 2 6 I) and continuous down-regulation of NF \u03ba B (blue, Fig.  6 J), leading to lower CCL5 secretion (red, Fig.  6 J, L). Even in response to a high midkine level, the rapid dissociation of the CCL4\u2013CCR8 complex weakens NF \u03ba B activation (blue, Fig.  6 L) and CCL5 production (red, Fig.  6 L). When   is decreased ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - ), the faster association of the CCL4\u2013CCR8 complex (red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}=0.12\\to 1.2$$\\end{document} b 2 - = 0 . 12 \u2192 1 . 2 6 I, K) activates NF \u03ba B (blue, Fig.  6 J, L) faster, providing the production efficiency of CCL5 (red, Fig.  6 J, L) and, thus, sustained tumor growth. Because of the independent topological structure of the receptor binding networks among CCL4\u2013CCR5 and CCL4\u2013CCR8, the changes in   or  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 +  do not affect the CCL4\u2013CCR5 dynamics in the presence of the low and high midkine levels (blue, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - 6 C, E, I, and K). Fig. 6 Effect of the association ( ) and dissociation ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + ) rates of CCL4\u2013CCR8 binding on the intracellular dynamics of microglia and tumor growth. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - A  CCL5 levels at various midkine concentrations and association rates ( ).  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + B  CCL5 levels for various midkine levels when   while  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}=1.2,12,120$$\\end{document} b 2 + = 1 . 2 , 12 , 120  is fixed. Changes in the [CCL4\u2013CCR5] and [CCL4\u2013CCR8] complex levels ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}=0.12$$\\end{document} b 2 - = 0 . 12 C ) and NF \u03ba B/CCL5 ( D ) as   is increased in the absence of midkine.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + E ,  F  Same as in  C ,  D  in response to the high midkine levels.  G  CCL5 levels for various midkine concentrations and dissociation rates ( ) and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - H  when   while  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}=0.012,0.12,1.2$$\\end{document} b 2 - = 0 . 012 , 0 . 12 , 1 . 2  fixed.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}=12$$\\end{document} b 2 + = 12 I \u2013 L  Changes in the [CCL4\u2013CCR5]/[CCL4\u2013CCR8] complex levels.  I ,  K  and NF \u03ba B/CCL5 ( J ,  L ) as   is increased in the absence ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - I ,  J ) and a high level ( K ,  L ) of midkine. Asthma-induced core control system In Fig.  7 , we investigate the role of decorin in the regulation of pre-existing dynamics of CCL4\u2013CCR8 in two-track receptor kinetics in Eqs. ( 18 )\u2013( 22 ). Figure  7 A shows time courses of levels of CCR8 and DCN\u2013CCR8 complex in response to high ( D  = 200\u2009nM) and low ( D  = 2\u2009nM) decorin stimuli from asthma-induced reprogrammed T cells. The DCN\u2013CCR8 complex is fully formed in the presence of high expression of decorin (red dashes, Fig.  7 A) while low binding activities are observed in response to low decorin input (blue, Fig.  7 A). On the other hand, this DCN\u2013CCR8 formation upon high decorin stimulus interferes with accumulation of the CCR8/CCL4\u2013CCR8 complex (red dashes, Fig.  7 B) by taking up the CCR8 molecules (red dashes, Fig.  7 B). Here, the initial condition was [ R 2 ](0) = 50,  ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}](0)=0$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] ( 0 ) = 0 ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}](0)=0$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ( 0 ) = 0 . The phase planes in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}](0)=0$$\\end{document} [ D \u22c5 R 2 \u00af ] ( 0 ) = 0 7 C, D show the corresponding flow of the solutions of the receptor binding with various initial conditions in response to low ([ D ] = 2\u2009nM in Fig.  7 C) and high ([ D ] = 200\u2009nM in Fig.  7 D), respectively. By defining thresholds for these intracellular variables, th D  = 23 for the DCN\u2013CCR8 complex and th L  = 14 for the CCL4\u2013CCR8 complex, we can define two different phenotypic modes, i.e., the pro-tumorigenic   and anti-tumorigenic  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$({{\\mathbb{P}}}_{{\\rm{t}}})$$\\end{document} ( P t )  modes, as follows: \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$({{\\mathbb{P}}}_{{\\rm{a}}})$$\\end{document} ( P a ) 1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\rm{{\\mathbb{P}}}}}_{t}=\\{([\\overline{D\\cdot {R}_{2}}],[\\overline{{L}_{4}\\cdot {R}_{2}}])\\in {{\\rm{{\\mathbb{R}}}}}^{2}:[\\overline{D\\cdot {R}_{2}}] < {th}_{D},[\\overline{{L}_{4}\\cdot {R}_{2}}] > {th}_{L}\\},$$\\end{document} \u2119 t = { ( [ D \u22c5 R 2 ] , [ L 4 \u22c5 R 2 ] ) \u2208 \u211d 2 : [ D \u22c5 R 2 ] < t h D , [ L 4 \u22c5 R 2 ] > t h L } , Figure  2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\rm{{\\mathbb{P}}}}}_{a}=\\{([\\overline{D\\cdot {R}_{2}}],[\\overline{{L}_{4}\\cdot {R}_{2}}])\\in {{\\rm{{\\mathbb{R}}}}}^{2}:[\\overline{D\\cdot {R}_{2}}] > {{t}{h}}_{D},\\,[\\overline{{L}_{4}\\cdot {R}_{2}}] < {th}_{L}\\}.$$\\end{document} \u2119 a = { ( [ D \u22c5 R 2 ] , [ L 4 \u22c5 R 2 ] ) \u2208 \u211d 2 : [ D \u22c5 R 2 ] > t h D , [ L 4 \u22c5 R 2 ] < t h L } . 7 C and D illustrates the pro-tumorigenic (high expression of the CCL4\u2013CCR8 complex, low level of the DCN\u2013CCR8 complex) and anti-tumorigenic (degradation of the CCL4\u2013CCR8 complex, high accumulation of the DCN\u2013CCR8 complex) in a   plane. A low decorin level ([ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]-[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] \u2212 [ D \u22c5 R 2 \u00af ] D ] = 2) induces one stable SS (Fig.  7 C) where suppression of the DCN\u2013CCR8 complex formation and promotion of CCL4\u2013CCR8-binding activities induce the tumorigenic status ( ), by upregulation of NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t \u03ba B and CCL5. In contrast, the heavy formation of the DCN\u2013CCR8 complex and decreased activity of CCL4\u2013CCR8 binding are induced under high decorin conditions ([ D ] = 200; Fig.  7 D; one stable SS). In this tumor microenvironment, the system induces down-regulation of NF \u03ba B and CCL5, thus leading to the anti-tumorigenic phenotype ( ). Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 7 E shows the dose\u2013response curves of [CCL5] level for various decorin stimuli. Since decorin directly inhibits CCL4\u2013CCR8 binding in microglia, an appropriate range of the decorin level is required to effectively suppress CCL5 expression. Figure  7 F illustrates these characterized response patterns of an increase in the DCN\u2013CCR8 complex formation and a decrease in the CCL4\u2013CCR8 binding with respect to DCN levels. An increase in the decorin level ([ D ]) leads to the phenotypic transition from the tumorigenic mode ( ) to the anti-tumorigenic status ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t ), while a decrease in [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a D ] induces the reverse ( ) switching. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}\\to {{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P a \u2192 P t Fig. 7 Role of decorin in dynamics of CCL4\u2013CCR5/CCL4\u2013CCR8 receptor binding. Time courses of levels of CCR8/DCN\u2013CCR8 complex ( A ) and CCR8/CCL4\u2013CCR8 complex ( B ) in response to high ( D  = 200\u2009nM) and low ( D  = 2\u2009nM) decorin stimuli. Initial condition: [ R 2 ](0) = 50,  ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}](0)=0$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] ( 0 ) = 0 ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}](0)=0$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ( 0 ) = 0 . Dynamics of the core control ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}](0)=0$$\\end{document} [ D \u22c5 R 2 \u00af ] ( 0 ) = 0 ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ) system ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 18 )\u2013( 22 ) in the phase plane in response to low ([ D ] = 2\u2009nM in ( C )) and high ([ D ] = 200\u2009nM in ( D )) levels of the decorin, together with a schematic of anti-tumorigenic ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\bar{D\\cdot {R}_{2}}] > t{h}_{{\\rm{D}}}$$\\end{document} [ D \u22c5 R 2 \u00af ] > t h D ) and tumorigenic ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\bar{{L}_{4}\\cdot {R}_{2}}] < t{h}_{{\\rm{L}}}$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] < t h L ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\bar{D\\cdot {R}_{2}}] < t{h}_{{\\rm{D}}}$$\\end{document} [ D \u22c5 R 2 \u00af ] < t h D ) regions in the DCN\u2013CCR8/CCL4\u2013CCR8 plane, respectively. Steady states marked with circles.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\bar{{L}_{4}\\cdot {R}_{2}}] > t{h}_{{\\rm{L}}}$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] > t h L E  Steady states of [CCL5] in response to various decorin levels.  F  Binding response to decorin in the core control system. *th D  = 23, th L  = 14. Decorin on the asthma-induced re-T cells plays an important role in reducing optic glioma growth . We test how the intercellular receptor dynamics on the T cell-microglia respond to reduction (or acceleration) of decorin expression from asthma-free conditions (or asthma development) by introducing a fluctuating decorin function (Fig.  21 8 A):  . (Base parameter:  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$D(t)=100\\cos (\\pi t/120)+100$$\\end{document} D ( t ) = 100 cos ( \u03c0 t / 120 ) + 100 =10\u2009nM.) In response to the initial decreasing decorin level, the trajectory of the DCN\u2013CCR8 complex solution follows the upper branches of the response curve (red circle curve, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{DCN}}}=\\frac{{b}_{3}^{-}}{{b}_{3}^{+}}$$\\end{document} K D DCN = b 3 \u2212 b 3 + 7 F) and jumps down to the lower values on the branch around [ D ] = 20. Thus, while   remains constant, a decrease in the decorin level on re-T cells (red arrows, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] 8 A) leads to the chemical dissociation of the DCN\u2013CCR8 complex but accumulation of   (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] 8 B) following the SS. CCL4\u2013CCR8 complex branch (blue diamond curve, Fig.  7 F), resulting in up-regulation of NF \u03ba B and CCL5 (Fig.  8 C). This essentially increases the growth potential of the optic glioma (Fig.  8 D), switching from the  off  state ( ) to the  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a on  state ( ) of glioma growth. When the decorin is delivered from asthma-induced re-T cells (blue arrows, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 8 A), the whole process of binding activities is reversed following the reverse direction on the solution branches in Fig.  7 F, i.e., up-regulation of DCN\u2013CCR8 complex and down-regulation of   (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] 8 B), which leads to suppression of NF \u03ba B and CCL5 (Fig.  8 C), and thus the critical transition of the  on  state ( ) back to the  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t off  state ( ) of glioma growth. Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 8 D shows time courses of tumor populations in response to either constant or varying decorin: (i) low decorin ([ D ] = 2, blue dashes), (ii) high decorin ([ D ] = 200, black dots), and (iii) fluctuating decorin levels (Fig.  8 A). The low decorin level induces  -phase (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 7 C), therefore, leading to midkine-mediated, faster glioma growth (blue dashed). When [ D ] is high, the receptor binding system induces the   TME (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 7 D), resulting in asthma-controlled suppression of tumor growth (black dashed). On the other hand, fluctuating decorin induces alternating phenotypic switches between   (blue zone) and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a  (pink zone) phases at  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t t  =  t 1 ,  t 2 ,  t 3 ,  t 4  (Fig.  8 C), which leads to either slow (blue region in Fig.  8 D) or fast (pink region in Fig.  8 D) tumor growth in   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a -zones, respectively, and eventually leads to an intermediate tumor size at final time (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 8 D). These computational results are in good agreement with recent experimental observation , where decorin expression from asthma-induced re-T cells in the brain TME significantly inhibited fast optic glioma growth. Thus, the expression level of the DCN\u2013CCR8 complex relative to the given CCL4\u2013CCR8 complex level in the given TME can be an important index in predicting the onset of optic glioma in the clinics. Thus, we introduce the following index for the scaled  21 -to- \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ]  ratio at time  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] t : Thus, if  3 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${R}_{De}(t)=\\frac{[\\overline{D\\cdot {R}_{2}}](t)/{th}_{D}}{[\\overline{{L}_{4}\\cdot {R}_{2}}](t)/{th}_{L}}.$$\\end{document} R D e ( t ) = [ D \u22c5 R 2 ] ( t ) / t h D [ L 4 \u22c5 R 2 ] ( t ) / t h L . R De  > 1, the system is decorin-induced anti-tumorigenic state for the optic glioma; otherwise, the system is tumorigenic, indicating a poor prognosis. Figure  8 E shows the decorin index ( R De ) and tumor volume at the final time corresponding to these three cases. The low (or high) index  R De  (blue, Fig.  8 E) is associated with fast (or slow) tumor growth (red, Fig.  8 E) while the average value of  R De  from fluctuating decorin stimuli indicates an intermediate level of the tumor formation potential. In Fig.  8 F, we show the negative correlation between the decorin index  R De  and tumor size. The  R De  and tumor size were calculated from levels of   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ]  and scaled cancer cell populations at the final time in response to various decorin input values ([ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] D ]\u2009=\u20090\u2013200). An increase in the decorin level from asthma-induced T cells results in an increase in  R De , which in turn suppresses NF \u03ba B, thus leading to diminished CCL5 production and suppression of the growth potential of the NF1-associated optic pathway gliomas . 21 Fig. 8 Effect of fluctuating decorin on dynamics of receptor binding and tumor growth. Time courses of binding activities ( B ), NF \u03ba B and CCL5 ( C ) in response to fluctuating decorin stimulus ( A ):  .  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$D(t)=100\\cos (\\pi t/120)+100$$\\end{document} D ( t ) = 100 cos ( \u03c0 t / 120 ) + 100 D  Time courses of the tumor cell populations in response to a fixed ([ D ] = 2 (blue dashes); [ D ] = 200 (black dots)) and fluctuating decorin level. Fluctuating decorin expression induces transitions between  - and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t -phenotypes, leading to transient glioma growth over time ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a t 1 ,  t 2 ,  t 3 ,  t 4 ). The decorin-dominant  -regions were shaded in pink in ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t C ,  D ).  E  The scaled  -to- \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ]  ratio (called  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] R De ) and tumor size for three decorin conditions in ( D ).  F  Negative correlations between the tumor volume and  R De . Base parameter:  =10\u2009nM. Other parameters are given in Table  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{{\\rm{D}}}^{{\\rm{DCN}}}=\\frac{{b}_{3}^{-}}{{b}_{3}^{+}}$$\\end{document} K D DCN = b 3 \u2212 b 3 + 1 . Initial conditions: [ R 2 ](0) = 50,  ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}](0)=0$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] ( 0 ) = 0 ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}](0)=0$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ( 0 ) = 0 . \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}](0)=0$$\\end{document} [ D \u22c5 R 2 \u00af ] ( 0 ) = 0 In Fig.  9 , we investigate the effect of the relative strength of the dissociation to the association in DCN\u2013CCR8-binding activities, i.e., , on the core control system when embedded in the fluctuating decorin environment in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}={b}_{3}^{-}/{b}_{3}^{+}$$\\end{document} K D DCN = b 3 \u2212 / b 3 + 8 A. In controls ( 10), the decorin-induced fluctuation in mutual antagonism between  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}=$$\\end{document} K D DCN =  (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] 9 A) and   (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 9 B) leads to the continuous transition between  - and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a -modes (middle, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 9 D) and alternation in the  R De  index (red, Fig.  9 C), thus generating a step-like tumor growth pattern (red solid, Fig.  9 E). Here,   value in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${R}_{{\\rm{De}}}^{{\\rm{ave}}}$$\\end{document} R De ave 9 C was calculated as an average value of  R De  at high ( t  =  t 1 ,  t 3 ,  t 5  in Fig.  9 B) and low ( t  =  t 2 ,  t 4  in Fig.  9 B) decorin time points. An increase in   ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}$$\\end{document} K D DCN ) induces up-regulation of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}=10\\to 1000$$\\end{document} K D DCN = 10 \u2192 1000  and down-regulation of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ]  (black dots, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 9 A, B), maintaining the   phase (top, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 9 D) regardless of decorin fluctuation. These lead to a sustained low decorin index (black dots, Fig.  9 C) and fast tumor growth (dotted, Fig.  9 E). On the other hand, a decrease in   ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}$$\\end{document} K D DCN ) induces down-regulation of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}=10\\to 0.1$$\\end{document} K D DCN = 10 \u2192 0.1  and up-regulation of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ]  (blue dashes, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 9 A, B), sustaining the   phase (bottom, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 9 D) regardless of various decorin levels. These result in a very high  R De  value (blue dashed, Fig.  9 C) and significant tumor suppression (blue, Fig.  9 E). Fig. 9 Effect of the decorin binding ratio on phenotypic transitions in the core control system. Time courses of the concentrations of the CCL4\u2013CCR8 complex ( A ), DCN\u2013CCR8 complex ( B ) for various ratios  =0.1, 10, 1000\u2009nM in response to the fluctuating decorin in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}$$\\end{document} K D DCN 8 A.  C  The decorin index ( R De ) at high and low decorin points ( t  =  t ,  i i  = 1, \u2026, 5 in ( B )) for three cases.  D  The corresponding phenotypic transitions between anti-tumorigenic and tumorigenic modes when   is varied.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{D}^{{\\rm{DCN}}}$$\\end{document} K D DCN E  Time courses of the scaled tumor sizes for three cases. Sensitivity analysis To further quantify the influence of each parameter on the local system\u2019s behavior, we extended our analysis by conducting a sensitivity analysis on midkine levels and the binding kinetic parameters. The analysis allows us to identify which parameters are sensitive to key variables such as concentrations of [CCL4 \u22c5 CCR5] complex, [CCL4 \u22c5 CCR8] complex, [DCN \u22c5 CCR8] complex, NF \u03ba B, and [CCL5], and the cancer cell population. The sensitivity results underscore the dynamic and nonlinear nature of the midkine\u2013CCL4\u2013microglia axis and point to potential therapeutic targets for modulating optic glioma progression through fine-tuned intervention in chemokine-receptor interactions. A range   ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{P}_{i}^{min},{P}_{i}^{max}]$$\\end{document} [ P i min , P i max ] i  = 1, \u2026, 7) for each of the parameters ( ) was chosen with the minimum ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{\\rm{MDK}}],{b}_{1}^{+},{b}_{1}^{-},{b}_{2}^{+},{b}_{2}^{-},{b}_{3}^{+},{b}_{3}^{-}$$\\end{document} [ MDK ] , b 1 + , b 1 \u2212 , b 2 + , b 2 \u2212 , b 3 + , b 3 \u2212 ) and maximum ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${P}_{i}^{min}$$\\end{document} P i min ) values, and we divided each range into 10,000 intervals of uniform length. (Other parameters are fixed as in Table  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${P}_{i}^{max}$$\\end{document} P i max 1 .) For a given parameter, a partial rank correlation coefficient (PRCC) value in the range of [\u2212 1, 1] is calculated. A sign of the PRCC value indicates whether an increase (or decrease) in the parameter value will lead to an increase (+) (or decrease (\u2212)) in the concentration of the main variable. The magnitude of the PRCC value indicates the correlation strength. Figure  10  shows the PRCC values of the concentrations/densities of biochemical variables ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] , NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] \u03ba B ( F ), CCL5 ( L 5 ), and tumor density ( C )) at a given time ( t  = 20, 50, 100). The levels of [CCL4 \u22c5 CCR5], [CCL4 \u22c5 CCR8], NF \u03ba B, and [CCL5], and the tumor size are positively correlated with midkine. However, the changes in midkine have the reverse effect on its counterpart, the [DCN \u22c5 CCR8] complex. The association rate   is positively correlated with variables such as [CCL4 \u22c5 CCR5], NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + \u03ba B, [CCL5], and cancer cell, as an increase in   promotes the complex formation and downstream activation (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + 3 ). In contrast,   shows a negative correlation with these tumor-promoting variables as faster dissociation diminishes complex stability and suppresses the downstream signal transduction (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - 3 ). On the other hand, the association and dissociation of the CCL4\u2013CCR5 chemical reaction is confined to the downstream variables that are regulated via CCR-mediated signaling due to the model structure. Thus, the levels of the [CCL4 \u22c5 CCR8] and [DCN \u22c5 CCR8] complexes remain unchanged in response to changes in  , showing no correlation. In a similar fashion, the association (or dissociation) rate of CCL4-CCR8 binding shows positive (or negative) correlations with variables in the pathway, such as the concentrations of the [CCL4 \u22c5 CCR8] complex, NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+},{b}_{1}^{-}$$\\end{document} b 1 + , b 1 - \u03ba B, [CCL5], and tumor size, while showing a negative (or positive) correlation with the concentration of the [DCN \u22c5 CCR8] complex. Due to the mutual antagonism between [CCL4 \u22c5 CCR8] and [DCN \u22c5 CCR8], the exact opposite sensitivities of   to those main variables in the signaling track are observed. Again, changes in these rates in the second route ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+},{b}_{3}^{-}$$\\end{document} b 3 + , b 3 - ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+},{b}_{2}^{-}$$\\end{document} b 2 + , b 2 - ) have little effect on [CCL4 \u22c5 CCR5] in the pathway of the other track, as partially illustrated in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+},{b}_{3}^{-}$$\\end{document} b 3 + , b 3 - 6 . Fig. 10 Sensitivity analysis. General Latin hypercube sampling (LHS) scheme and partial rank correlation coefficient (PRCC) were performed on the model. The colors in each sub-box indicate PRCC values using the method of Marino et al.  with a sample size of 10,000. 36 Table 1 Model parameters for system Par Description Dimension value Refs. (dimensionless value) Microglia module \u03bb 4 Signaling source of CCL4 1.3863 \u00d7 10 \u22123 \u2009\u03bcM/h (0.0277) 136 , 137 c 1 Midkine signaling rate of CCL4 1.3863 \u00d7 10 \u22122  (0.2773) 7 , 9 , 21 , 136 , 137 c 2 Hill-type constant 2\u2009\u03bcM (40) 9 , 138 c 3 T cells signaling rate of CCL4 1 (1) 7 , 9 , 21 , 136 , 137 c 4 Hill-type constant 2\u2009\u03bcM (0.1) 9 , 138 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + Association rate of CCL4\u2013CCR5 binding 12\u2009\u03bcM \u22121 \u2009h \u22121  (0.6) 139 \u2013 141 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - Dissociation rate of CCL4\u2013CCR5 binding 0.18\u2009h \u22121  (0.18) 139 \u2013 141 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + Association rate of CCL4\u2013CCR8 binding 12\u2009\u03bcM \u22121 \u2009h \u22121  (0.6) 139 \u2013 141 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - Dissociation rate of CCL4\u2013CCR8 binding 0.12\u2009h \u22121  (0.12) 139 \u2013 141 \u03bc 4 Decay rate of CCL4 1.3863\u2009h \u22121  (1.3861) 136 , 137 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 + Association rate of Decorin\u2013CCR8 binding 12\u2009\u03bcM \u22121 \u2009h \u22121  (0.6) 139 \u2013 141 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 - Dissociation rate of Decorin\u2013CCR8 binding 0.12\u2009h \u22121  (0.12) 139 \u2013 141 \u03bc D Decay rate of Decorin 0.1733\u2009h \u22121  (0.1733) 142 \u03bb F Signaling source of NF \u03ba B 3.151 \u00d7 10 \u22122 \u2009\u03bcM/h (0.0788) 143 \u2013 148 k 1 CCL4 \u22c5 CCR5 complex signaling rate of NF \u03ba B 7.877 \u00d7 10 \u22122 \u2009\u03bcM/h (0.1969) 143 \u2013 148 k 2 Hill-type constant 1.5 \u00d7 10 \u22122 \u2009\u03bcM (0.3) 7 , 9 , 21 k 3 CCL4 \u22c5 CCR8 complex signaling rate of NF \u03ba B 7.877 \u00d7 10 \u22122 \u2009\u03bcM/h (0.1969) 143 \u2013 148 k 4 Hill-type constant 2 \u00d7 10 \u22122 \u2009\u03bcM (0.4) 7 , 9 , 21 \u03bc F Decay rate of NF \u03ba B 0.3151h \u22121  (0.3151) 143 , 144 r M Growth rate of microglia 3.8946 \u00d7 10 \u22124 \u2009h \u22121  (3.8946 \u00d7 10 \u22124 ) 149 , 150 M 0 Carrying capacity of Microglia 4 \u00d7 10 \u22125 \u2009g/cm 3  (1) 149 , 150 T cells & re-programming T cells module \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{{T}_{{\\rm{a}}}}$$\\end{document} \u03bb T a Re-programming T cells signaling rate of Decorin 2079.6\u2009\u03bcM cm 3 /h g (4.1592) Est r T Growth rate of T cells 2.6 \u00d7 10 \u22121 \u2009h \u22121  (0.26) 151 \u2013 154 T 0 Carrying capacity of T cells 1.0 \u00d7 10 \u22124 \u2009g/cm 3  (1) 155 , 156 \u03bb T Translation rate (T cells \u2192 re-programming T cells) by Asthma 1 \u00d7 10 \u22122 \u2009h \u22121  (0.01) Est \u03bb T1 Re-translation rate (re-programming T cells \u2192 T cells) 1 \u00d7 10 \u22122 \u2009h \u22121  (0.01) Est \u03bc Ta Decay rate of re-programming T cells 0.0041\u2009h \u22121  (0.0041) 157 , 158 a 1 IL-2 signaling rate of T cell growth rate 2.5 (2.5) 61 , 159 , 160 a 2 Hill-type constant 50\u2009IU/ml (1.6667) 61 , 159 , 160 \u03bc I Decay rate of IL-2 0.6931\u2009h \u22121  (0.6931) 161 \u2013 163 Optic glioma module k 5 NF \u03ba B signaling rate of CCL5 0.1109\u2009\u03bcM/h (1.5843) 7 , 9 , 21 , 22 , 164 k 6 Hill-type constant 0.3\u2009\u03bcM (0.75) 145 \u2013 148 k 7 Microglia signaling rate of CCL5 1 (1) Est k 8 Hill-type constant 4 \u00d7 10 \u22126 \u2009g/cm 3  (0.1) 149 , 150 \u03bc 5 Decay rate of CCL5 1.3863\u2009h \u22121  (1.3863) 164 r Growth rate of optic glioma 4.1667 \u00d7 10 \u22124 \u2009h \u22121  (4.1667 \u00d7 10 \u22124 ) 149 , 150 , 165 , 166 k 9 CCL5 signaling rate of optic glioma 15 (15) Est k 10 Hill-type constant 7 \u00d7 10 \u22122 \u2009\u03bcM (1) 7 , 9 , 21 , 22 C 0 Carrying capacity of optic glioma 4 \u00d7 10 \u22125 \u2009g/cm 3  (1) 149 , 150 , 165 , 166 Est  Estimated. The detailed sensitivity analysis for the whole system is given in  Supplementary information . The sensitivity analysis was performed using the method from Marino et al.  and files available from the website of Denise Kirschner\u2019s Lab:  36 http://malthus.micro.med.umich.edu/lab/usadata/ . In order to examine the detailed sensitivity of chemical reaction parameters, Monte Carlo simulations are performed as illustrated in Figs.  11 \u2013 13 . In Fig.  11 , the association and dissociation rate constants (  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + ) corresponding to the reaction  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 -  are randomly sampled. In Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{1}]\\rightleftharpoons [\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 ] + [ R 1 ] \u21cc [ L 4 \u22c5 R 1 \u00af ] 11 A, a three-dimensional Monte Carlo sensitivity analysis is performed to examine the combined effect of the association ( ) and dissociation ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + ) rate constants on the steady-state concentration of the CCL4\u2013CCR5 complex ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - ). Each pair of ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] ) values is randomly sampled from logarithmic distributions spanning two orders of magnitude (1.2\u2013120\u2009\u03bcM \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+},{b}_{1}^{-}$$\\end{document} b 1 + , b 1 - \u22121 \u2009h \u22121  and 0.018\u20131.8\u2009h \u22121 , respectively), and 10,000 simulations are conducted. The resulting 3D scatter distribution revealed an inverse relationship between the binding and unbinding rates, where larger   and smaller  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 +  produced higher equilibrium levels of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - . Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] 11 B, C shows the sensitivity of the   complex formation to variations in the association ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] ) and dissociation ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + ) rate constants, respectively. The resulting scatter plot demonstrates that the  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 -  level increases with  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] , approaching saturation as receptor sites become occupied (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + 11 B). In contrast, the scatter distribution indicates a clear negative correlation between   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - , where an increase in  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ]  leads to a pronounced reduction in the steady-state of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - . Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] 11 D shows how variations in   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 +  indirectly influence [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - L 5 ] levels through the kinetic modulation of the upstream ligand\u2013receptor binding and NF \u03ba B activation. Figure  11 E presents the co-relationship between the kinetic parameters   and the cancer cell population ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+},{b}_{1}^{-}$$\\end{document} b 1 + , b 1 - C ). The results show that the enhanced ligand\u2013receptor binding strength, achieved through higher   or lower  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + , leads to an elevated  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - C  level over time. Figure  11 F shows the histogram of the steady-state   obtained from all 10,000 Monte Carlo runs. The unimodal distribution indicates a predominant equilibrium range, but with a measurable spread reflecting parameter uncertainty. This statistical representation highlights the intrinsic uncertainty of biochemical kinetics and provides a probabilistic measure of model robustness. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] Fig. 11 Monte Carlo simulation of CCL4\u2013CCR5 binding kinetics. A  Three-dimensional sensitivity surface showing the combined effect of   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 +  on  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - . Dependence of the steady-state complex  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ]  on the association ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] B ) and dissociation ( C ) rate constants. Dependence of the cytokine [ L 5 ] level ( D ) and cancer cell population ( E ) on   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + .  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{-}$$\\end{document} b 1 - F  Distribution of the final   concentrations obtained from all Monte Carlo runs, illustrating variability due to kinetic uncertainty.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] n  = 10,000 Monte Carlo samples; log-uniform parameter sampling. Following the analysis of the  L 4 \u2212 R 1  binding kinetics, we next investigate the second ligand-receptor interaction,  , by varying the kinetics parameters  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{2}]\\rightleftharpoons [\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 ] + [ R 2 ] \u21cc [ L 4 \u22c5 R 2 \u00af ]  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 +  and using 10,000 Monte Carlo samples drawn from log-uniform distributions. Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - 12 A\u2013C summarize the sensitivity analysis of the   complex. Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] 12 B shows that an increase in the association rate constant ( ) promotes complex formation, while Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + 12 C demonstrates that the dissociation rate   is negatively correlated with the steady-state of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - . Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] 12 A presents the joint sensitivity surface for  , revealing that strong binding affinity (high  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+},{b}_{2}^{-}$$\\end{document} b 2 + , b 2 - , low  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + ) maximizes receptor occupancy, consistent with the trend observed for the  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 -  (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 \u22c5 R 1 \u00af ] 11 ). Figure  12 D\u2013F illustrate how these variations propagate through the downstream network. In Fig.  12 D, changes in   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 +  significantly alter the [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - L 5 ] production, indicating that the  L 4 \u2212 R 2  interaction strongly regulates cytokine expression via NF \u03ba B-mediated transcriptional control. Figure  12 E shows the corresponding effect of cancer cell population, where enhanced ligand\u2013receptor binding strength leads to accelerated tumor growth, demonstrating the pro-tumoral influence of excessive receptor activation. Figure  12 F presents the probability distribution of the equilibrium   values obtained from all 10,000 simulations, showing a unimodal yet broadened profile that quantifies the inherent variability caused by kinetic uncertainty. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] Fig. 12 Monte Carlo simulation of CCL4\u2013CCR8 binding kinetics. A  Three-dimensional sensitivity surface showing the combined effect of   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 +  on  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - . Dependence of the steady-state complex  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ]  on the association ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] B ) and dissociation ( C ) rate constants. Dependence of the cytokine [ L 5 ] level ( D ) and cancer cell population ( E ) on   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{+}$$\\end{document} b 2 + .  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{2}^{-}$$\\end{document} b 2 - F  Distribution of the final   concentrations obtained from all Monte Carlo runs, illustrating variability due to kinetic uncertainty.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] n  = 10,000 Monte Carlo samples; log-uniform parameter sampling. Finally, to assess the stochastic sensitivity of the   binding kinetics, Monte Carlo simulations are performed with 10,000 random samples of the association ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[D]+[{R}_{2}]\\rightleftharpoons [\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D ] + [ R 2 ] \u21cc [ D \u22c5 R 2 \u00af ] ) and dissociation ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 + ) rate constants drawn from log-uniform distributions. The simulation results provide a quantitative understanding of how variability in decorin-receptor interactions influences downstream signaling and tumor progression under asthmatic conditions ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 - I asthma  = 1). Figure  13 A\u2013C illustrates the direct effect of the kinetic parameters on the equilibrium concentration of the   complex. In Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 13 B, the complex level increases with the higher  , reflecting the enhanced binding propensity of decorin to [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 + R 2 ]. Figure  13 C shows that an increase in   significantly decreases the steady-state complex concentration due to accelerated dissociation. Changes in  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 -  in response to stochastic perturbations in  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ]  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 -  are larger than the previous two kinetics in Figs.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 + 11  and  12 . The combined parameter dependence in Fig.  13 A reveals a distinct nonlinear surface, where strong binding (high  , low  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 + ) produces the largest  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 -  accumulation, suggesting that stable decorin\u2013receptor engagement is critical for sustaining the signaling pathway. Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 13 D demonstrates that a decrease in   or an increase in  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 +  leads to an elevation in [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 - L 5 ] production, indicating that decorin binding kinetics indirectly modulates the [ L 5 ]-associated cytokine feedback loop via NF \u03ba B and microglia. Figure  13 E shows that high  D \u2212 R 2  binding affinity correlates with reduced tumor growth, consistent with the tumor-suppressive role of decorin-mediated receptor signaling observed in experiments . Finally, Fig.  21 13 F summarizes the overall distribution of the final   concentrations from all Monte Carlo runs, exhibiting a right-skewed unimodal pattern that reflects the nonlinear sensitivity of the system to stochastic variations in reaction rates. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] Fig. 13 Monte Carlo simulation of Decorin\u2013CCR8 binding kinetics. A  Three-dimensional sensitivity surface showing the combined effect of   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 +  on  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 - . Dependence of the steady-state complex  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ]  on the association ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] B ) and dissociation ( C ) rate constants. Dependence of the cytokine [ L 5 ] level ( D ) and cancer cell population ( E ) on   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{+}$$\\end{document} b 3 + .  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{3}^{-}$$\\end{document} b 3 - F  Distribution of the final   concentrations obtained from all Monte Carlo runs, illustrating variability due to kinetic uncertainty.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] n  = 10,000 Monte Carlo samples; log-uniform parameter sampling. A series of Monte Carlo simulations (10,000 samples) are performed to quantify the sensitivity of the ligand\u2013receptor binding kinetics ([ L 4 ] + [ R 1 ], [ L 4 ] + [ R 2 ], and [ D ] + [ R 2 ]) to stochastic variations in their association and dissociation rates. The results consistently revealed that strong binding affinity (high association rate, low dissociation rate) enhances complex formation and downstream cytokine activity, whereas weak binding attenuates signaling and tumor cell growth, emphasizing the critical role of receptor-level kinetic heterogeneity in modulating the overall tumor microenvironment response. To account for the intrinsic stochasticity arising from discrete molecular interactions in small reaction volumes, the Gillespie stochastic simulation algorithm (SSA)  is employed to describe the reversible binding process between ligand [ 37 \u2013 39 L 4 ] and receptor [ R 1 ]: Since Gillespie\u2019s method operates on discrete molecule counts, the molar concentration [ 4 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{1}]\\mathop{\\mathop{\\rightleftharpoons }\\limits^{{b}_{1}^{+}}}\\limits_{{b}_{1}^{-}}[\\overline{{L}_{4}\\cdot {R}_{1}}].$$\\end{document} [ L 4 ] + [ R 1 ] \u21cc b 1 + b 1 - [ L 4 \u22c5 R 1 \u00af ] . L 4 ] and [ R 1 ] are converted to molecule number   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${N}_{[{L}_{4}]}$$\\end{document} N [ L 4 ] , using the relation  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${N}_{[{R}_{1}]}$$\\end{document} N [ R 1 ] N  =  X X  \u00d7  N A  \u00d7  V , where  N A  is Avogadro\u2019s number (=6.022 \u00d7 10 23 ) and  V  is reaction volume (=5 \u00d7 10 \u221215 ) . Accordingly, the association rate constant with molar unit  40  (units: \u03bcM \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{1}^{+}$$\\end{document} b 1 + \u22121 \u2009h \u22121 ) is converted to the molecular stochastic rate   (units: molecule \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{1}^{+}={b}_{1}^{+}/({N}_{{\\rm{A}}}V)$$\\end{document} k 1 + = b 1 + / ( N A V ) \u22121 \u2009h \u22121 ), while the dissociation rate constant   retains its unit of h \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{1}^{-}$$\\end{document} k 1 - \u22121 . In the Gillespie framework, the propensities of the forward and reverse reactions are therefore where  5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{\\mathrm{on}}^{{L}_{4}{R}_{1}}={k}_{1}^{+}{N}_{[{L}_{4}]}{N}_{[{R}_{1}]},\\,{k}_{off}^{{L}_{4}{R}_{1}}={k}_{1}^{-}{N}_{[\\overline{{L}_{4}\\cdot {R}_{1}}]},$$\\end{document} k on L 4 R 1 = k 1 + N [ L 4 ] N [ R 1 ] , k o f f L 4 R 1 = k 1 \u2212 N [ L 4 \u22c5 R 1 ] , N  ( i ) denotes the dimensionless molecular copy number of each species. Thus, the units of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$i=[{L}_{4}],[{R}_{1}],[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} i = [ L 4 ] , [ R 1 ] , [ L 4 \u22c5 R 1 \u00af ]  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{{\\rm{on}}}^{{L}_{4}{R}_{1}}$$\\end{document} k on L 4 R 1  are h \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{{\\rm{off}}}^{{L}_{4}{R}_{1}}$$\\end{document} k off L 4 R 1 \u22121 , and the time to the next reaction event( \u03c4 ) is sampled from an exponential distribution: where  6 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau =-\\frac{\\mathrm{ln}\\,({r}_{1})}{{k}_{\\mathrm{on}}^{{L}_{4}{R}_{1}}+{k}_{off}^{{L}_{4}{R}_{1}}},$$\\end{document} \u03c4 = \u2212 ln ( r 1 ) k on L 4 R 1 + k o f f L 4 R 1 , r 1  \u2208 (0, 1) is a uniformly distributed random number. The reaction channel (association or dissociation) is then chosen according to the probability  . The initial concentrations of [ \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{k}_{on}^{{L}_{4}{R}_{1}}}{{k}_{on}^{{L}_{4}{R}_{1}}+{k}_{off}^{{L}_{4}{R}_{1}}}$$\\end{document} k o n L 4 R 1 k o n L 4 R 1 + k o f f L 4 R 1 L 4 ] and [ R 1 ] are set to 0.05\u2009\u03bcM, corresponding to   molecules per species (150 \u2248 0.05 \u00d7 10 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${N}_{[{L}_{4}]}={N}_{[{R}_{1}]}\\approx 150$$\\end{document} N [ L 4 ] = N [ R 1 ] \u2248 150 \u22126  \u00d7  N A  \u00d7  V ) . This formulation guarantees that the stochastic simulation remains dimensionally consistent with the original biochemical rate constants. 41 Deterministic trajectories are obtained by numerically integrating the mass-action ODEs, whereas stochastic trajectories are generated using the Gillespie direct algorithm, which explicitly samples the time to each reaction event based on probabilistic reaction propensities. For each reaction, 500 stochastic realizations are performed to visualize the range of molecular fluctuations. The temporal dynamics of the reaction   is shown in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{1}]\\rightleftharpoons [\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 ] + [ R 1 ] \u21cc [ L 4 \u22c5 R 1 \u00af ] 14 A, where the time courses of molecule concentrations (solid curves;  ) from the deterministic system are overlaid with stochastic trajectories (shadows) representing individual realizations. Similar settings are applied to the other ligand\u2013receptor binding reactions ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}],[\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 ] , [ L 4 \u22c5 R 1 \u00af ]  and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{2}]\\rightleftharpoons [\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 ] + [ R 2 ] \u21cc [ L 4 \u22c5 R 2 \u00af ] ), where each reaction is implemented using the Gillespie SSA under identical computational conditions. All parameters and state variables in these reactions are consistently converted from molar concentrations to molecule-based units to ensure accurate representation of discrete molecular interactions within a confined intracellular volume. Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[D]+[{R}_{2}]\\rightleftharpoons [\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D ] + [ R 2 ] \u21cc [ D \u22c5 R 2 \u00af ] 14 B and C shows the binding processes of  ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{2}]\\rightleftharpoons [\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 ] + [ R 2 ] \u21cc [ L 4 \u22c5 R 2 \u00af ] , respectively. In all cases, the simulations from the deterministic system well represent the expected mean-field kinetics, while the stochastic system exhibits noticeable temporal fluctuations due to discrete reaction events and random timing between association and dissociation processes. The ensemble of stochastic trajectories converges to the deterministic mean, confirming model consistency while emphasizing the influence of intrinsic molecular noise in low copy number regimes. These findings demonstrate that ligand\u2013receptor interactions associated with stochastic variability may become functionally relevant in developing anti-tumor therapy in confined TME domains. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[D]+[{R}_{2}]\\rightleftharpoons [\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D ] + [ R 2 ] \u21cc [ D \u22c5 R 2 \u00af ] Fig. 14 Stochastic simulation of ligand\u2013receptor binding using the Gillespie algorithm. Gillespie algorithm-based stochastic simulation of the reversible reaction   ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{1}]\\rightleftharpoons [\\overline{{L}_{4}\\cdot {R}_{1}}]$$\\end{document} [ L 4 ] + [ R 1 ] \u21cc [ L 4 \u22c5 R 1 \u00af ] A ),   ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[{L}_{4}]+[{R}_{2}]\\rightleftharpoons [\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 ] + [ R 2 ] \u21cc [ L 4 \u22c5 R 2 \u00af ] B ), and   ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[D]+[{R}_{2}]\\rightleftharpoons [\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D ] + [ R 2 ] \u21cc [ D \u22c5 R 2 \u00af ] C ), showing intrinsic molecular noise around the deterministic mean. Asthma-induced suppression of optic glioma formation In Fig.  15 , we investigate how an asthma attack in the lung can shape the immune microenvironment of the optic glioma in the brain through priming the T cells in the blood circulation. Asthma-induced inflammation leads to the reprogramming of T cells, so-called re-T cells, with high expression of decorin , a key regulator in the brain TME 21 . In the absence of asthma, T-cell deficiency, and the decorin-free condition (red dashes, Fig.  42 15 B) induces the  -mode (high  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t  and low  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ; red dashed curve in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 15 C) in the core binding receptor system, thus tight up-regulation of NF \u03ba B (blue in the left column, Fig.  15 D) in microglia. The beginning and end points of the solution curve ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}](t)$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ( t ) ) are marked in \u2018B\u2019 and \u2018E\u2019 in the pink  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}](t)$$\\end{document} [ D \u22c5 R 2 \u00af ] ( t )  box in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 15 C. This low decorin index ( R De ; red in the left column, Fig.  15 D) and elevated production of CCL5 from microglia (blue in the left column, Fig.  15 E) essentially lead to fast growth of optic glioma in brain (red dashes, Fig.  15 F). On the other hand, an increasing population of the re-T cells in brain (blue solid line, Fig.  15 A) from asthma attack with accumulating decorin (blue solid, Fig.  15 B) leads to convergence of the solution in the receptor module to the  -mode (low  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a  and high  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ; blue curve in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] 15 C). The location at the final time was marked in \u2018E\u2019 in the blue   box in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 15 C. This substantial elevation in the decorin level on microglia from asthma-induced T cell reprogramming is a crucial factor in modulating the tumor-associated signaling pathway, increasing  R De  (red, 2nd column, Fig.  15 D). This shift from   to  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t  mode reduces the availability of CCL4\u2013CCR8, a central activator of the NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a \u03ba B pathway, thereby down-regulating NF \u03ba B signaling (blue, 2nd column, Fig.  15 D) and suppressing secretion of CCL5 on microglia (red, Fig.  15 E). Thus, the system eventually inhibits tumor growth in the presence of asthma (blue solid, Fig.  15 F). This finding aligns well with experimental data , reinforcing the observation that asthma-induced immune reprogramming can effectively disrupt tumor-promoting pathways. These results suggest that the decorin-mediated suppression of NF 21 \u03ba B can mediate a protective effect of asthma on the onset of optic glioma and asthma, despite its well-documented inflammatory nature, and can exert an unexpected tumor-suppressive effect as described in ref.  . 21 Fig. 15 Asthma-controlled tumor growth. Time courses of densities of the re-T cells ( A ) and decorin levels ( B ) in response to the onset of the asthma attack (solid) compared to control (dashed, no asthma).  C  Dynamics of the core control ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] ) system in the phase plane and phenotypic transition in the presence and absence of asthma.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] D  Expression level of NF \u03ba B and the decorin index ( R De ) at the final time.  E  Comparison with experimental data (red): Asthma attack suppresses CCL5 expression by microglia.  F  Time courses of the tumor population in both cases. In Fig.  16 , we investigate the impact of the frequency of asthma attacks on the immune changes in the TME in the brain and optic glioma progression. In order to take into account the periodic asthma attacks with a period  \u03c4 a , we modify Eqs. ( 29 ) and ( 30 ) as follows: 7 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{dT}{dt}={r}_{T}T\\left(1-\\frac{T}{{T}_{0}}\\right)-{\\lambda }_{T}T\\mathop{\\sum }\\limits_{i=1}^{{N}_{a}}{I}_{[{t}_{i},{t}_{i}+{h}_{A}]}+{\\lambda }_{T1}{T}_{a}\\left(1-\\mathop{\\sum }\\limits_{i=1}^{{N}_{a}}{I}_{[{t}_{i},{t}_{i}+{h}_{A}]}\\right),$$\\end{document} d T d t = r T T 1 \u2212 T T 0 \u2212 \u03bb T T \u2211 i = 1 N a I [ t i , t i + h A ] + \u03bb T 1 T a 1 \u2212 \u2211 i = 1 N a I [ t i , t i + h A ] , where  8 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d{T}_{a}}{dt}={\\lambda }_{T}T\\mathop{\\sum }\\limits_{i=1}^{{N}_{a}}{I}_{[{t}_{i},{t}_{i}+{h}_{A}]}-{\\lambda }_{T1}{T}_{a}\\left(1-\\mathop{\\sum }\\limits_{i=1}^{{N}_{a}}{I}_{[{t}_{i},{t}_{i}+{h}_{A}]}\\right)-{\\mu }_{a}{T}_{a}.$$\\end{document} d T a d t = \u03bb T T \u2211 i = 1 N a I [ t i , t i + h A ] \u2212 \u03bb T 1 T a 1 \u2212 \u2211 i = 1 N a I [ t i , t i + h A ] \u2212 \u03bc a T a . N a  is the number of total asthma attacks,  \u03c4 a  =  t  \u2212  i +1 t ,  i i  = 1, \u2026,  N a \u22121,  h A  is the time duration of an asthma attack, and  I [ ( \u22c5 ) is the indicator function that gives 1 on the time interval [ a ,  b ] a ,  b ] and 0 otherwise. A relatively frequent asthma attack ( \u03c4 a  = 5 days, red, Fig.  16 A) induces a large population of re-T cells (red solid, Fig.  16 B) and over-expressed decorin in the brain immune environment (red solid, Fig.  16 C), maintaining the system in the  -mode (red solid, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{a}$$\\end{document} P a 16 D) with a consistently high decorin index ( R De ( t ) > 1, red in Fig.  16 E) and down-regulation of NF \u03ba B (solid red in Fig.  16 G) and CCL5 (solid blue in Fig.  16 G). Thus, the asthma-induced, sustained anti-tumorigenic environment (blue box, bottom ( \u03c4 a  = 5), Fig.  16 H)) leads to suppression of optic glioma (red solid, Fig.  16 F) compared to fast tumor growth in controls (no asthma, black dotted, Fig.  16 F). On the other hand, a system exposed to less frequent asthma symptoms (once a month,  \u03c4 a  = 30 days) only generates two peaks of re-T cells (blue dashed, Fig.  16 B), expression level (blue dashed, Fig.  16 C) and index (blue dashed, Fig.  16 E) of decorin during 60 days. Thus, the cumulative impact of these immune-modulating cycles between  - and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a -modes (blue dashed, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 16 D) leads to fluctuations in NF \u03ba B and CCL5 secretion. Thus, a reduction in tumor burden during an asthma attack with the system in a  -mode leads to slower tumor growth (blue dashed, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 16 F) compared to control (black dotted, Fig.  16 F), but still a tumor develops under the larger degree of asthma-free conditions in the  -mode (pink boxes,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t \u03c4 a  = 30, Fig.  16 H). Figure  16 H illustrates phenotypic changes in response to various periods of asthma attacks ( \u03c4 a  = 5, 10, 20, 30 days). As  \u03c4 a  is increased, the TME selects the frequent temporal immune transitions in preference to all time  -mode. For instance, in response to asthma attacks every 5\u201310 days, the cancer cell population is reduced by more than 25% compared to the control (no-asthma) condition, highlighting the potential tumor-suppressive role of asthma-induced immune reprogramming in the optic glioma microenvironment. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a Fig. 16 Effect of the frequency of asthma ( \u03c4 a ) attacks on dynamics of tumor growth. A  Temporal changes in asthma attacks for two cases ( \u03c4 a  = 5, 30). Time courses of the concentrations of the re-T cells ( B ), decorin ( C ), decorin index ( E ), normalized tumor populations relative to control ( F ), and NF \u03ba B/CCL5 ( G ), and internal dynamics in the phase plane ( D ) in response to asthma stimuli in  A .  H  Phenotypic changes of microglia in response to a periodic asthma attack with various  \u03c4 a  ( \u03c4 a \u2009=\u20095,10,20,30). Therapeutic approach We now investigate the effect of re-T cell infusion on tumor dynamics. Recent advances in adoptive cell therapy demonstrated the potential of transferring functionally specialized T cells to modulate tumor immunity, most notably through tumor-infiltrating lymphocyte (TIL) therapy, where patient-derived T cells from the tumor site are expanded ex vivo and re-infused to target cancer cells . We assume that re-T cells are injected over time intervals [ 43 \u2013 46 t ,  i t  +  i h T ],  i  = 1, \u22ef ,  N t  with the duration  h T , injection strength  s T , and a period  \u03c4 (= t t \u2212 i +1 t , \u2200  i i  = 1, \u22ef ,  N \u22121). Here,  t N t  is the total number of re-T cell injections. Thus, we have the following for the injection rate of re-T cells ( u T ( t )) in Eq. ( 30 ) during 60 days: Figure  9 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${u}_{T}(t)={s}_{T}\\mathop{\\sum }\\limits_{i=1}^{{N}_{t}}{I}_{[{t}_{i},{t}_{i}+{h}_{T}]}.$$\\end{document} u T ( t ) = s T \u2211 i = 1 N t I [ t i , t i + h T ] . 17 B and C shows time courses of the concentrations of re-T cells (Fig.  17 B) and decorin (Fig.  17 C) in response to two injection schemes ( \u03c4 t  = 5(red), 20(blue), Fig.  17 A) while the total amount of infused re-T cells is fixed. With the frequent injection scheme ( \u03c4 t  = 5), the intercellular system pushes the solution   to the anti-tumorigenic phase (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}](t),[\\overline{D\\cdot {R}_{2}}](t)$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ( t ) , [ D \u22c5 R 2 \u00af ] ( t ) 17 D) and maintains the high  R De  index (red, Fig.  17 E). The relatively low, fluctuating levels of the NF \u03ba B along the solution trajectory (Fig.  17 D), thus steady  -status ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a \u03c4 t  = 5, Fig.  17 H) lead to suppression in tumor growth (red, Fig.  17 F) via suppressed CCL5 levels. On the other hand, injection of the larger population of re-T cells every 20 days (blue dashed, Fig.  17 B) induces higher expression of decorin and a larger decorin index ( R De ; blue dashed, Fig.  17 E) at peak points. However, the less frequent schedule ( \u03c4 t  = 20) pushes the dynamic system to the  -mode (curves on the bottom, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 17 G) in the lower mode of  R De  fluctuation (Fig.  17 E,  ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{T}}}_{{\\rm{a}}}=\\{t\\in [0,60]:{R}_{{\\rm{De}}}(t) < 1\\}={\\sum }_{j}^{4}{{\\mathbb{T}}}_{{\\rm{a}},j}={\\sum }_{j}^{4}[{t}_{2j-1},{t}_{2j}]$$\\end{document} T a = { t \u2208 [ 0 , 60 ] : R De ( t ) < 1 } = \u2211 j 4 T a , j = \u2211 j 4 [ t 2 j \u2212 1 , t 2 j ] t 1  = 0,  t 8  = 60). The suppressed NF \u03ba B (Fig.  17 G;   regions in Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 17 H) over these multiple time intervals ( ) leads to a cycle of growth and suppression of the optic glioma (blue dashed, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{T}}}_{{\\rm{a}}}={\\sum }_{j}^{4}{{\\mathbb{T}}}_{{\\rm{a}},j}$$\\end{document} T a = \u2211 j 4 T a , j 17 F) via up- and down-regulation of CCL5. These results imply that, given constant resources of re-T cells, the scheduling of injection can make a significant difference in controlling the onset of the optic glioma via the immunosuppressive efficacy of re-T cells and the downstream tumor-promoting signaling mediated by CCL5. These findings provide quantitative evidence supporting strategically timed re-T cell therapies as a potential immunomodulatory approach for controlling optic glioma progression. Fig. 17 Anti-tumor efficacy and intercellular receptor dynamics in response to re-T cells injection. A  Injection rate of re-T cells ( u T ) with different periods ( \u03c4 t  = 5, 20). Time courses of the concentrations of re-T cells ( B ), decorin ( C ), expression levels of decorin ( B )  R De  ( E ), and normalized tumor cell populations ( F ) in response to re-T cell injection in ( A ). Expression levels of NF \u03ba B along the solutions trajectories with  \u03c4 t  = 5 ( D ) and  \u03c4 t  = 20 ( G ) over a time cycle [0, 20] in the   plane.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]-[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] - [ D \u22c5 R 2 \u00af ] H  Temporal changes between   and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a  modes with various  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t \u03c4 t  ( \u03c4 t  = 5, 10, 20, 30). Although TIL therapy has shown remarkable clinical efficacy in some cancers, its broader application is limited by the technical challenges and time required for ex vivo expansion. To overcome these limitations, an alternative strategy involves administering IL-2 directly to support the proliferation and activation of both endogenous T cells and therapeutically infused reprogrammed T cells (re-T cells) . This method retains the immuno-stimulatory benefits of IL-2 while avoiding the logistical hurdles of ex vivo manipulation, potentially enabling a more streamlined and accessible immunotherapy. In order to test the effect of IL-2 on anti-tumor efficacy, we introduce a new variable  47 \u2013 49 I  for the concentration of IL-2 and use a modified version of Eqs. ( 29 ) and ( 30 ) in the absence of re-T cells injection, for the densities of T cells and re-T cells and IL-2 concentration ( I ) as follows: 10 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{dT}{dt}={r}_{T}\\left(1+\\frac{{a}_{1}{I}^{k}}{{a}_{2}^{k}+{I}^{k}}\\right)T\\left(1-\\frac{T}{{T}_{0}}\\right)-{\\lambda }_{{\\rm{T}}}T{I}_{asthma}+{\\lambda }_{T1}{T}_{{\\rm{a}}}(1-{I}_{asthma}),$$\\end{document} d T d t = r T 1 + a 1 I k a 2 k + I k T 1 \u2212 T T 0 \u2212 \u03bb T T I a s t h m a + \u03bb T 1 T a ( 1 \u2212 I a s t h m a ) , 11 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d{T}_{{a}}}{dt}={r}_{{Ta}}\\left(\\frac{{a}_{1}{I}^{k}}{{a}_{2}^{k}+{I}^{k}}\\right){T}_{a}\\left(1-\\frac{{T}_{a}}{{T}_{0}}\\right)+{\\lambda }_{{\\rm{T}}}T{I}_{asthma}-{\\lambda }_{T{1}}{T}_{a}(1-{I}_{asthma})-{\\mu }_{a}{T}_{a},$$\\end{document} d T a d t = r Ta a 1 I k a 2 k + I k T a 1 \u2212 T a T 0 + \u03bb T T I a s t h m a \u2212 \u03bb T 1 T a ( 1 \u2212 I a s t h m a ) \u2212 \u03bc a T a , where  12 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{dI}{dt}={u}_{I}(t)-{\\mu }_{I}I$$\\end{document} d I d t = u I ( t ) \u2212 \u03bc I I a 1  is the enhancement rate by IL-2 in the growth terms in T cells and re-T cells with Hill coefficients ( ,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${a}_{2}\\in {{\\mathbb{R}}}^{+}$$\\end{document} a 2 \u2208 R + ),  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k\\in {{\\mathbb{Z}}}^{+}$$\\end{document} k \u2208 Z + u I ( t ) is injection rate of IL-2, and  \u03bc I  is the natural decay rate of IL-2. In the simulation, IL-2 is injected over time intervals [ t ,  i t  +  i h I ],  i  = 1, \u22ef ,  N I  with a duration  h I , the base injection rate  s I , and the fixed period  \u03c4 I ( =  t \u2212 i +1 t , \u2200  i i  = 1, \u22ef ,  N I \u22121). Here,  N I  is the total amount of IL-2 dose. Thus, we have the following for the injection rate of IL-2 ( u I ( t )) in Eq. ( 12 ): 13 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${u}_{I}(t)={s}_{I}\\mathop{\\sum }\\limits_{i=1}^{{N}_{{\\rm{I}}}}{I}_{[{t}_{i},{t}_{i}+{h}_{I}]}.$$\\end{document} u I ( t ) = s I \u2211 i = 1 N I I [ t i , t i + h I ] . Figure  18 A shows the anti-tumor efficacy of the IL-2 treatment for various injection period  \u03c4 I  and total amount of IL-2 dose ( T IL\u22122 ). While the total amount of IL-2 administered remains constant in a given row, the injection rate for each administration is changed according to the injection period. For a fixed period ( \u03c4 I ), the total injection dose is positively correlated with anti-tumor efficacy. However, there is a jump in anti-tumor efficacy from low efficacy to high efficacy as  T IL-2  is increased. While the injection amount ( T IL-2 ) is too low, the IL-2 infusion is not able to suppress the onset of the optic glioma (blue, bottom rows, Fig.  18 A) regardless of periods. On the other hand, the IL-2 treatment is effective in suppressing tumor growth for all periods when the total dose is large enough (yellow, top rows, Fig.  18 A). For  T IL-2  between 100 and 200\u2009IU/ml, the anti-tumor efficacy curve illustrates the nonlinear feature, attaining the maximal outcomes for intermediate periods. For instance, when  T IL-2  = 150\u2009IU/ml (Fig.  18 B), the cancer cell population at the final time decreases initially as  \u03c4 I  increases ( \u03c4 I  = 5 \u2192 9) but increases again after passing the critical period point ( \u03c4 I  > 13). Thus, an intermediate value (e.g.,  \u03c4 I  = 9) leads to the maximal anti-tumor efficacy. When  T IL-2  = 110\u2009IU/ml (Fig.  18 C), the smaller injection period tends to show low anti-tumor efficacy overall, but it shows strong nonlinearity in the intermediate values of  \u03c4 I . For instance, the cancer cell population for  \u03c4 I  = 13 is lower than the population for  \u03c4 I  = 14. The injection of IL-2 every 15 days leads to the best anti-tumor outcomes (black arrow, Fig.  18 C). In Fig.  18 D\u2013I, we investigate the dynamics of the system of three cases in Fig.  18 B ( \u03c4 I \u2009=\u200913,14,15) in detail for a fixed amount of IL-2 (110\u2009IU/ml). The injection of IL-2 with the different periods ( \u03c4 I \u2009=\u200913,14,15 with injection rates  s I \u2009=\u200922, 22, 27.5\u2009IU/(ml days), respectively) provides different temporal profiles of IL-2 concentration (Fig.  18 D) and a fluctuating population of re-T cells (Fig.  18 E) in the TME. When IL-2 was injected every 15 days ( \u03c4 I \u2009=\u200915,  s I  = 27.5\u2009IU/(ml days)), the larger presence of re-T cells in TME maintains more anti-tumorigenic phases (Fig.  18 H) compared to other cases ( \u03c4 I \u2009=\u200913, Fig.  18 F;  \u03c4 I \u2009=\u200914, Fig.  18 G) due to down-regulation of   and up-regulation of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ]  for most of the time, thus suppressing NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ] \u03ba B (Fig.  18 K) and reducing tumor growth (black dotted curve, Fig.  18 L) significantly. On the other hand, the relatively lower number of re-T cells from more frequent injection with lower doses (blue and red, Fig.  18 E) induces the system to stay longer in the tumorigenic status (Fig.  18 F and G) and leads to up-regulation of NF \u03ba B and faster tumor growth (blue and red, Fig.  18 L). Despite the same total amount of IL-2, the injection with  \u03c4 I \u2009=\u200913 (blue, Fig.  18 D) results in slower tumor growth compared to the case with  \u03c4 I \u2009=\u200914 (Fig.  18 L) due to larger peaks of the re-T cell population and a longer stay in the   mode. These findings indicate that more frequent IL2 injections with shorter resting intervals-even at the same dose and number of administrations- may significantly enhance therapeutic effectiveness. \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{a}$$\\end{document} P a Fig. 18 Therapeutic effect of IL-2 on optic glioma development. A  Anti-tumor efficacy in response to IL-2 infusion with various injection periods ( \u03c4 I , days) and total amount of IL-2. Scaled tumor size at final time for various  \u03c4 I  (5\u2009\u2264\u2009 \u03c4 I \u2009\u2264\u200920) when the total amount of IL-2 is fixed (150\u2009IU/ml ( B ) and 110\u2009IU/ml ( C )). Time courses of the concentrations of IL-2 ( D ) and CCL4\u2013CCR8 and DCN\u2013CCR8 complexes ( F \u2013 H ), population of re-programmed T cells ( E ), NF \u03ba B levels on the phase plane ( I \u2013 K ), and normalized tumor cell populations ( L ) in response to IL-2 injection with three different periods ( \u03c4 I  = 13, 14, 15) with a fixed total amount (110\u2009IU/ml). Although higher doses per injection may improve anti-tumor efficacy (Fig.  18 ), practical considerations such as side effects and treatment cost highlight the importance of developing strategies that maximize therapeutic benefits using minimal dosing. Therefore, we now investigate an optimal IL2 treatment protocol through systematic analysis. For each injection rate of IL-2, we identify the second optimal injection time ( t 2 ) to maintain the   mode after initial injection of IL-2 at  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{a}$$\\end{document} P a t  =  t 1 . Figure  19 A shows the waiting time distribution, i.e., . For instance, when  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}}^{\\ast }={\\tau }_{{\\rm{I}}}^{\\ast }({s}_{{\\rm{I}}})={t}_{2}-{t}_{1}$$\\end{document} \u03c4 I \u2217 = \u03c4 I \u2217 ( s I ) = t 2 \u2212 t 1 =25.2, the fluctuating re-T cell population (dashed red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}}^{\\ast }$$\\end{document} \u03c4 I \u2217 19 C) from the second injections of IL-2 after 13.25 days ( ) induces strong decorin receptor binding to keep the solution trajectory in  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}}^{\\ast }=13.25$$\\end{document} \u03c4 I \u2217 = 13.25  phase (dashed red, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 19 D) over the time interval [0,  t 2  +  \u03f5 ] ( \u03f5  > 0, small). In this case, other injection time points  t  ( i i  = 3\u2026, red dashed, Fig.  19 E) can also be determined by monitoring the solutions   to remain in the anti-tumorigenic state for all time (red dashed, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}](t),[\\overline{D\\cdot {R}_{2}}](t)$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ( t ) , [ D \u22c5 R 2 \u00af ] ( t ) 19 D) via corresponding peaks of re-T cells (red dashed, Fig.  19 C). A routine injection of IL-2 with the smaller fixed period ( ;  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}} < {\\tau }_{{\\rm{I}}}^{\\ast }$$\\end{document} \u03c4 I < \u03c4 I \u2217 \u03c4 I  = 9, blue circle in Fig.  19 A) according to Eq. ( 13 ) after the initial injection can also maintain   mode (blue, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 19 D) via higher peaks in re-T cells supply (blue, Fig.  19 C) but with more administrative costs and possible side effects due to the larger total amount of IL-2. However, a period injection of IL-2 with   ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}} > {\\tau }_{{\\rm{I}}}^{\\ast }$$\\end{document} \u03c4 I > \u03c4 I \u2217 \u03c4 I  = 18, yellow triangle, Fig.  19 A) is not strong enough to activate re-T cells (yellow dotted, Fig.  19 C) the solution   in the intracellular module on microglia transits between  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}](t),[\\overline{D\\cdot {R}_{2}}](t)$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ( t ) , [ D \u22c5 R 2 \u00af ] ( t ) - and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a -modes (yellow dotted, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 19 D). While   is increased as dose is increased,  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}}^{\\ast }$$\\end{document} \u03c4 I \u2217  remain almost constant for larger  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}}^{\\ast }$$\\end{document} \u03c4 I \u2217 s I  ( s I  > 25.2, Fig.  19 A), indicating similar anti-tumor efficacy despite higher costs. Even if an optimal schedule can be chosen for various IL-2 injection rates ( s I ) in Fig.  19 A, each dose lead to a different total amount of IL-2 in the 60-day treatment window (Fig.  19 B). For instance, higher single-dose injections lead to accelerated, rapid expansion of the re-T cell population and sustained  -mode due to higher decorin levels, but this also results in the higher total injection amount, thus the higher cost and an increase in side effect potential. Thus, it is beneficial for clinics to reduce cost when the clinical outcome is similar. Figure  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 19 E\u2013I illustrates the system dynamics in response to three injection schedules of IL-2 ( s I \u2009=\u200920 (red), 25.2 (red), 40 (black)). While the three cases induce different temporal profiles of IL-2 (Fig.  19 E) and re-T cells (Fig.  19 F), the solution stays in the   mode (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 19 G), leading to sustained, low CCL5 levels (Fig.  19 H), thus suppression of tumor growth (Fig.  19 I). However, the injection with a rate of 25.2\u2009IU/ml ( ) minimizes the cost (red dot, Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}}^{\\ast }=13.25\\,{\\rm{days}}$$\\end{document} \u03c4 I \u2217 = 13.25 days 19 B). Thus, this minimizing strategy can be the most efficient therapeutic strategy in the clinic. However, considering that optic glioma predominantly affects pediatric patients, minimizing the per-injection dose\u2014even at the expense of shorter injection intervals\u2014may be more favorable in terms of patient quality of life. Fig. 19 Strategic injection of IL-2 to improve anti-tumor efficacy. A  The waiting time distribution of the second injection   after the first injection of IL-2 to maintain the  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\tau }_{{\\rm{I}}}^{\\ast }={\\tau }_{{\\rm{I}}}^{\\ast }({s}_{{\\rm{I}}})={t}_{2}-{t}_{1}$$\\end{document} \u03c4 I \u2217 = \u03c4 I \u2217 ( s I ) = t 2 \u2212 t 1  mode for various injection rates ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a s I ).  B  Total amount of IL-2 corresponding to the cases in ( A ). Time courses of re-T cells ( C ) and solution trajectories in the phase plane ( D ) for three cases ( \u03c4 I \u2009=\u20099 (O), 13.25 (x), 18 (\u0394) in  A ). Time courses of IL-2 level ( E ), re-T cell population ( F ), trajectories of solutions in the phase plane ( G ), CCL5 levels ( H ), and scaled cancer cell populations ( I ) in response to three (blue, red, black dots) IL-2 infusions in ( B ).",
  "discussion": "Discussion Previous studies suggested the strong correlation between asthma (or other immune diseases such as allergy or atopy) and low risk of developing brain tumors based on clinical observations and epidemiological data . For instance, Roncarolo et al. and other researchers demonstrated the negative association between asthma and brain tumors in children 50 \u2013 53 . In particular, experimental evidence suggested that asthma-induced T cells with decorin expression may suppress the formation and progression of optic glioma, the most common brain tumor among children 50 , 54 \u2013 57 . However, the fundamental mechanism of the negative correlation between asthma development and the incidence of brain tumors in children has not been clearly understood. 21 , 58 In this work, we showed that optic glioma risk can be modulated by alterations in asthma-induced T cell function by interfering with immune-tumor interactions in brain TME. By inhibiting the conventional CCL4\u2013CCR8\u2013NF \u03ba B axis on microglia and reducing CCL5 production, asthma-driven decorin on these re-T cells plays an important role in suppressing glioma growth. T cells in brain TME mediates Nf1-optic glioma growth in mice, and in T cell-deficient mice, a tumor is not formed by murine optic glioma stem cells . Thus, a new type of primed T cell changes the tumor growth dynamics. We investigated how midkine from the optic nerve induces tumor growth due to CCL5 secretion by microglia 59  by carrying the conventional receptor binding (CCL4\u2013CCR5, CCL4\u2013CCR8) and activation of NF 13 , 60 \u03ba B (tumorigenic phase ( ); Figs.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t 2 \u2013 4 )  and how secretion of decorin from populated asthma-induced re-T cells in brain TME 9  can induce up-regulation of the DCN\u2013CCR8 complex ( 21 ) and down-regulation of  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{D\\cdot {R}_{2}}]$$\\end{document} [ D \u22c5 R 2 \u00af ]  (anti-tumorigenic mode;  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[\\overline{{L}_{4}\\cdot {R}_{2}}]$$\\end{document} [ L 4 \u22c5 R 2 \u00af ] ), leading to suppression of both NF \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a \u03ba B and CCL5 which in turn induces an anti-tumorigenic mode (Figs.  7 \u2013 9 ). This study identifies a novel anti-oncogenic mechanism by which asthma-induced T cell reprogramming exerts a protective effect against the progression of optic glioma through modulation of the tumor microenvironment. Specifically, asthma-assisted re-T cells secrete decorin, which inhibits CCL4\u2013CCR8 complex formation by competitively binding to CCR8, thereby reducing NF \u03ba B-mediated upregulation of CCL5, a cytokine known to enhance glioma cell proliferation. This asthma-induced effect on tumor suppression (Fig.  15 ) was consistently observed in experiments . Since the relative balance of binding between CCL4\u2013CCR8 and DCN\u2013CCR8 component leads to the critical decorin index,  21 R De  (in Eq. ( 3 ), to determine the suppression and enhancement of the optic glioma (Fig.  8 ), fluctuation in decorin in TME may change overall anti-tumor efficacy. We found that the intracellular system on microglia illustrates different dynamics on the key transition between  - and  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{t}}}$$\\end{document} P t -modes, thus anti-tumor efficacy, in response to repeated asthma attacks with various periods (Fig.  \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\mathbb{P}}}_{{\\rm{a}}}$$\\end{document} P a 16 ). Thus, patient-specific treatment or prevention protocols can be created when enough data and experiments on the more detailed mechanism are accumulated. These findings offer novel insights into the complex interplay between systemic immune responses and tumor dynamics, potentially paving the way for new therapeutic strategies that harness the protective effects of asthma-induced immune modulation. Recent advances in adoptive cell therapy have demonstrated the potential of transferring functionally specialized T cells to modulate tumor immunity, most notably through tumor-infiltrating lymphocyte (TIL) therapy, where patient-derived T cells from the tumor site are expanded ex vivo and re-infused to target cancer cells . By isolating these asthma-induced re-T cells from peripheral blood or lymphoid tissue, it may be possible to expand them ex vivo using cytokine stimulation (e.g., IL-2 or anti-CD3/CD28) 43 \u2013 46 . Thus, a novel new approach could involve isolating asthma-primed CD8 61 , 62 +  T cells, which naturally acquire a tumor-suppressive phenotype through chronic inflammatory conditions. Computational modeling revealed that optimal IL-2 delivery can amplify the population of these re-T cells in brain TME, supporting decorin-mediated anti-tumor effects (Fig.  17 ). When testing the anti-cancer efficacy of IL-2 administration, intriguingly, a more frequent and moderate dosing schedule yields efficient tumor suppression under constant total IL-2 amount (Fig.  18 ). These findings suggest a critical interplay between immune modulation, cytokine dynamics, and dosing strategies in shaping tumor outcomes in inflammatory contexts such as asthma. Our model provides a multi-organ modeling framework linking the asthma-induced immune environment and brain tumor progression, and proposes a new paradigm for adoptive cell transfer therapy. Unlike conventional TIL-based strategies, this approach incorporates asthma-induced reprogramming to enhance therapeutic specificity. Despite its importance and opening a new era of a new type of immunotherapy- organ-induced prevention-, experimental data on the complex network of asthma-T cells-microglia-tumor and inter-and intra-cellular signaling within those key immune cells is sparse. Thus, computational studies on the over-immune effects of these interactions on brain cancer risk , and on the sensitivity of the model predictions to key intracellular parameters may provide important insights to guide and create new experiments aimed at the development of new, innovative therapeutic strategies. 21 , 58 The proposed framework may generalize to other tumor-immune interactions beyond NF1-associated optic glioma. For instance, while mice with hyperglycemia may promote the growth of gliomas via RAGE expression and inhibition of immune responses, suppression of pro-inflammatory cytokines was shown to inhibit glioma subtypes in diabetic mice. There exist conflicting epidemiological studies on positive  and negative 63 \u2013 68  effects of diabetes on cancer development in glioma patients 69 \u2013 72 . Alzheimer\u2019s disease was also shown to have negative correlation with GBM development via signaling pathways such as PI3K/Akt/mTOR axis 73 . The mathematical framework in this work can be applied to identify the key signaling network with a similar inhibition mechanism and to develop new enhanced therapeutic approaches to preventing cancer. 74 \u2013 76 In this work, we did not take into account many microenvironmental factors, such as the midkine signaling pathway on the optic nerve , the effect of caffeic acid phenethyl ester on dampening microglia 77 , 78 , the multifaceted role of decorin-controlled IFN 21 \u03b3  in asthma and cancer , the role of decorin in the regulation of receptor tyrosine kinase (IGFR1, c-MET, EGFR) on other cells 79 \u2013 83  that may play critical roles in progression, invasion, and growth of gliomas, and the development of anti-cancer drugs. For instance, decorin was shown to inhibit the invasive capacity of GBM cells in the brain 84 \u2013 86 . While decorin-induced IFN 42 \u03b3  activity  plays an important role in maintaining lung tissue inflammation in asthma 79 , 80 , decorin enhances anti-oncogenic activities such as suppressing angiogenesis and metastatic potential in cancer progression 87 . However, the mathematical model in this work can serve as a first step toward further experimental design and more detailed modeling, such as hybrid multi-scale models 81 \u2013 83  by incorporating these brain tumor microenvironmental factors. It is also possible that other immune systemic diseases involving T lymphocytes, such as diabetes 87 \u2013 98 , eczema 73 , 99 , rheumatoid arthritis 53 , 100 , 101 , may also affect glioma development via a similar set of complex mechanisms. For instance, a group of studies 102 , 103  showed the inverse association of diabetes with glioma, while other groups showed contradictory or nonlinear results 99 . Further analysis and investigation of this correlation at the molecular biology level is necessary. 70 , 73 , 104 , 105 While the present model provides quantitative insights into the mechanistic link between asthma-associated immune signaling and optic glioma progression, it is formulated under a simple assumption of the well-mixed system without explicit spatial representation. However, cytokine diffusion and immune-cell migration play a significant role in regulation of tumor growth , tumor suppression 91 , 106 , angiogenesis 107 \u2013 110 , necrosis 111 , 112 , recurrence of tumor in the other hemisphere 113 , 114 , and delivery of the therapeutic agents through BBB 115 , 116  in spatially heterogeneous microenvironments. In particular, it is important to understand the heterogeneity in cell compositions and roles in two distinct organs, the lung\u2014where asthma-related T cell reprogramming originates\u2014and the brain, where an optic glioma develops. In order to develop a new optimal treatment method for the optic glioma, we plan to investigate these spatial aspects in future work. The model in this work provides a basic platform to better understand the spatio-temporal dynamics of the complete, asthma-optic glioma interactions and drug delivery. 117 \u2013 119",
  "upgrade_date": "2026-02-21 02:21:01"
}